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MANGE ÅRS RØYNSLE MED PIL OG BOGE 
 
Det er den svarte prikken 
midt i skiva du skal treffa, 
nett den, der 
skal pila stå og dirra! 
Men nett der treffer du ikkje. 
Du er nær, nærare, 
nei, ikkje nær nok. 
Så lyt du gå og plukka upp pilene, 
gå tilbake, prøva på nytt. 
Den svarte prikken tergar deg. 
Til du forstår pili 
som stend der og dirrar: 
Her er og eit midtpunkt. 
 
Olav H. Hauge 
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Summary 
Introduction 
Preparticipation health examinations are recommended in athletes (1), and mandatory in 
professional soccer players (2). The main aim is to reduce the prevalence of sudden cardiac death 
(SCD), which is 2-3 times more common in athletes than in the general population (3). The most 
common cause of SCD is hypertrophic cardiomyopathy in the USA, arrhythmogenic right 
ventricular cardiomyopathy in Italy, but what causes the highest risk in the Nordic countries was 
unknown (4;5). Electrocardiography (ECG) is a diagnostic tool to detect athletes with increased 
risk of cardiovascular (CV) disease and SCD, but descriptions of methodology are scarce and 
interpretation has often been left to personal experience (6). “Abnormal” ECG findings related 
to training are common in athletes, and a challenge to distinguish from pathological ECG 
findings (6). Blood pressure (BP) is recorded during screening examinations, and high BP 
accounts for the highest prevalence of abnormal findings (7). This has neither been emphasized 
as an isolated finding, nor in association to other CV risk factors. Hence, the main aims of this 
thesis were to 1) see if high BP (≥140/90 mmHg) was associated with other CV risk factors, 2) 
follow-up players with high BP, 3) describe the male professional soccer players’ 
electrocardiograms according to available recommendations and 4) to compare visual and 
computer-based ECG-measurements. 
 
Methods 
During a preparticipation training camp at La Manga in 2008, BP, ECG and echocardiography 
were recorded from 595 players aged 18-38 years. BP was registered as the mean of two 
consecutive resting BP recordings and related to heart rate (HR) and pulse pressure (PP) as 
indicators of increased sympathetic activity, and echocardiographic variables for left ventricle 
hypertrophy (LVH), left atrial enlargement (LAE) and systemic arterial compliance (SAC) (Paper 
I). Players with high BP still living in Norway were invited to a follow-up study of ambulatory BP 
(ABP) in 2010, and together with 26 matched controls with optimal BP (<120/70 mmHg), ABP 
was recorded during 24 hours without exercise (Paper II). ECGs from 587 players were 
interpreted according to the European Society of Cardiology’s (ESC) recommendations from 
2010, with specifications from Uberoi et al in 2011, and compared to the new Seattle criteria from 
2013. Choice of method, technical specifications and visual measurements with callipers on-
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screen of the averaged PQRST complex in each lead was described in detail (Paper III). Visual 
measurements were compared to computer-based measurements, to test for correlation and 
agreement between prevalence of abnormal ECGs. Based on the main differences, reference 
values for abnormal findings were adjusted, to tentatively increase the agreement between visual 
and computer-based measurements (Paper IV). 
 
 
Results 
BP was high in 39 (7%) of the players, and high normal (≥130/85 mmHg) in another 18% of the 
players. There was a significant association between increasing BP in groups, and increased HR, 
PP, indexed LV mass, LA volume, and decreased SAC. Two players with BP>160/100 mmHg 
and LV hypertrophy on echocardiography were temporarily restricted from activity (Paper I). 
High daytime ABP (≥135/85 mmHg) was unmasked in nine (35%) of the controls after ABP 
recording and more than half of the players had high ABP (≥120/70 mmHg) during the night 
(Paper II). The prevalence of abnormal ECGs was reduced from 29.3% to 11.2% by the new 
Seattle criteria. None of the players with abnormal ECGs according to the ESC’s 
recommendations only, had abnormal echocardiograms. Echocardiography alone did not detect 
important abnormality. All players, except the two hypertensives already mentioned, got medical 
clearance. (Paper III). Abnormal ECG findings were more common after computer-based 
versus visual measurements both according to the ESC recommendations (51% versus 29.5%), 
and the Seattle criteria (22% versus 11%). The disagreements were mainly due to “borderline” 
abnormal findings or misclassifications by the computer. With small adjustments of reference 
Figure 1. Picture from La Manga training camp in Spain, February 2008. 
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values, the agreement increased to moderate and good. None of the ECGs interpreted as normal 
by the computer-based algorithm was recommended follow-up after the initial screening (Paper 
IV). 
 
Perspectives 
The associations between BP and hypertensive subclinical organ damages in this young cohort of 
athletes emphasize the need for closer focus on BP measurements and standardized follow-up. 
The novel findings of masked HT and high BP during nighttime, together with lack of nocturnal 
dip in BP, are surprising in these young, slim and physically active athletes. Whether these, as in 
the general population, are independent risk factors for CV disease should be investigated in large 
prospective cohort-studies. 
   The Seattle criteria for interpreting ECG in athletes reduced the need for follow-up 
investigations, and based on echocardiographic evaluations this reduction increased the specificity 
of the Seattle criteria, without increasing the number of false negative ECGs. We experienced 
several difficulties when trying to decide the prevalence of abnormal ECGs in athletes, and 
revealed a need for new definitions of “standard” methodology. Reference values for abnormality 
should be adjusted dependent on measurement method. We can rely on normal computer-based 
interpretations according to the Seattle criteria, while abnormal computer-based ECG findings 
should be reread visually and maybe corrected. Echocardiographic evaluations seem unnecessary 
in all soccer players.  
Introduction 
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Introduction  
Background 
Sudden cardiac deaths (SCD) in sports are tragic events, especially for athletes and their relatives. 
But as great sport’s events like professional soccer games are broadcasted worldwide, these 
events also affect millions of people. The true incidence of sports related SCD  is hard to know, 
but is reported to be 0.3-3.6 per 100 000 persons per year, and is usually said to be two to three 
times more frequent in young athletes than in the general population (3). In attempts to prevent 
SCD, preparticipation health examinations are recommended in athletes (1), and mandatory in 
professional soccer players (2). The most common cause of SCD is hypertrophic cardiomyopathy 
in the USA, arrhythmogenic right ventricular cardiomyopathy in Italy, but what causes the 
highest risk in the Nordic countries is unknown (4;5). Some of the CV risk factors can be 
detected during screening and successfully treated, while others will lead to recommendations for 
restricted activity to reduce the risk of SCD (8-14). How many athletes who unnecessary have to 
abandon their career because of false positive screening results and how many athletes at risk 
eluding the wide mesh screening, is unknown. It is also dependent on type of investigations. The 
ESC recommends ECG to be part of the examinations because of an Italian study from 2006 
which claims that inclusion of ECG reduces the incidence of SCD by 89% (15;16). On the 
contrary, the American Heart Association does not recommend inclusion of ECG, because of its 
low sensitivity and specificity (17). Whether echocardiographic evaluations of all athletes catch 
even more athletes at risk, and only them, has not been proven, but both ECG and 
echocardiography became mandatory parts of the preparticipation cardiac screening of soccer 
players in 2008 (2). To gain more knowledge about the Norwegian athlete’s heart, the first 
mandatory screening of male professional soccer players in Norway was conducted as a research 
project in 2008.  
Demographic data related to gender, ethnicity and sports discipline 
SCD in young competitive athletes is five to nine times more common in males than females (18-
21). Hypertrophic cardiomyopathy as cause of death is more common in Afro-American than in 
white athletes (19). Development of athlete’s heart is related to gender and race, with different 
echocardiographic and electrocardiographic reference values for normality (22-25). Hence, 
ethnicity has great impact on screening results. As an increasing number of professional soccer 
Introduction 
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players in Norway are black, information of ethnicity is important when interpreting the results. 
Different athletic activities influence the formation of athlete’s heart in different ways, and also 
the incidence of SCD (26;27). In a study of 134 sports related cardiovascular SCD in the US, 
altogether 68% occurred in basketball (n=47) and football (n=45) (20). Many studies of 
preparticipation cardiac screening seems to ignore these differences and mix participants with 
different age, gender, ethnicity and sports disciplines (15;20;28-33).The Norwegian project 
offered a unique opportunity to study the development of athlete’s heart and prevalence of CV 
risk factors in a homogenous group of adult male professional soccer players, categorized by 
ethnicity. Screening is mandatory for both genders, but unfortunately the females were not 
included in this research project.  
 
Blood pressure in athletes 
Previous to the Olympic Games in London in 1948, the Nutrition 
Society on the nutrition of athletes realized they had few scientific data 
on the nutrition and physiology of athletes (34). So they performed a 
study of diet, hemoglobin and BP, while the athletes were gathered in 
London. Mean BP was 121/76±13/8 mmHg in participants from 
temperate countries. In western countries the prevalence of 
hypertension has been reported to be 14.4% and 21.2% in men aged 20-
29 and 30-39 years, respectively (35). The prevalence in physically active 
people and athletes has been considered to be lower than in the general 
population (36), but no studies have been designed to actually compare 
this. Until 1993 hypertension was defined according to the World Health Organization’s report 
from 1962, based on one BP recording (37). From 1993, repeated measurements of high BP are 
required for the diagnosis of hypertension (38). 
   Despite that high BP is the most common abnormal finding during preparticipation cardiac 
screening of athletes, there is little focus on measurement method, follow-up and CV 
consequences (7). OBP should be measured three times after 5-10 minutes sitting rest and 
registered as the mean of the last two measurements (38). ABP should be conducted on a day 
without exercise as an adjunct to OBP as it is superior to OBP in predicting CV events (38;39). 
The two measurement methods complement each other and define subgroups of white coat HT 
and masked HT (38). Athletes with high BP should be followed up according to national 
Introduction 
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guidelines for the general population as long as we don’t know if hypertension in athletes is less 
serious (40). Increased LV mass is considered as subclinical organ damage in people with 
hypertension (41;42), and increased left atrium size has been linked to the increased prevalence of 
atrial fibrillation in endurance athletes (43;44). Several studies have demonstrated increased LV 
mass in athletes (23), but no studies have investigated if this is associated with high BP in 
athletes. In the general population left atrium size also increases with BP, and whether this occurs 
in athletes with high BP is unknown (42;45;46). Nor is systemic arterial compliance (SAC), which 
is reduced in hypertensive patients (47), studied in young athletes with high BP.  
    High heart rate (HR) and pulse pressure (PP) have shown to be strong predictors for CV 
disease, and are both associated with increased sympathetic activity (48;49). In addition, increased 
HR also predicts development of essential HT (48). 
 
Electrocardiography 
 
Figure 2. Professor Willem Einthoven invented the first practical ECG device, the string galvanometer, in 1903. The weight 
was 270 kilograms and it required five technicians to be operated. The person’s arms and feet were dipped in salt solutions 
while the strength and rate of the heartbeat were registered on the chest. Einthoven was awarded the Nobel Prize in physiology 
and medicine in 1924, “for the discovery of the mechanism of the electrocardiogram”. Photo: Google pics. FPG/Hulton 
Archive/Getty Images. http://www.nobelprize.org/nobel_prizes/medicine/laureates/1924/einthoven-bio.html 
Introduction 
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Today ECG devices are carried in one hand and operated by one person, Einthoven’s original 
assignment of the letters P, Q, R, S and T to the various deflections as well as his equilateral 
triangle centered on the chest (figure 3), are still used. But 
to determine whether cardiac remodeling in athletes have 
a pathological component and if any ECG findings may 
help identify this type of remodeling, we need standards 
for all phases of the ECG procedure. The athlete’s 
position, lead placements and technical specifications of 
the ECG device can all influence the measurements of 
amplitudes, intervals, and diagnostic statements (50). 
Recommendations for measurement standards in 
quantitative ECG were first published in 1938 and have 
been revised several times since (51). The International 
Society for Computerized Electrocardiography state that 
all ongoing studies used for criteria development must clearly document electrode placement with 
precision (50). The only widely accepted written recommendations for ECG interval 
measurement before the digital era were published in 1997 by the European Committee for 
Proprietary Products (CPMP). They were based on annotating three consecutive sinus 
complexes, preferably from lead II (52). It’s reasonable to believe that during the last decade, 
when several studies of preparticipation screening have been published, digitalized ECG devices 
with built in algorithms for measuring intervals from the earliest onset to the latest offset of the 
waveform in all leads have gradually become more utilized. Small systematic differences in 
measurements, particularly with respect to diagnostically important global measures of QRS 
duration and QT interval, might be expected between different ECG devices, because of 
different methods for lead alignment and template formation (50). These differences in global 
measurement algorithms must be accounted for in comparative studies within individuals and 
between individuals (50). Since global PQRST measurements are systematically larger than 
measurements from representative complexes of individual leads, redefined normal values are 
also required (53).  
   Measurements can be performed manually on paper or on-screen, or they can be derived from 
the ECG software. A number of studies of QT measurements has shown relatively poor 
agreement between manual and automated ECG measurement methods (54), though somewhat 
better in healthy participants (55). Whether choice of method influences the prevalence of 
abnormal ECG findings in athletes, is hitherto unknown. “Abnormal” ECG findings related to 
Figure 3. Einthoven’s equilateral triangle 
Introduction 
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training are common in athletes, and are a challenge to distinguish from pathological ECG 
findings (16). The ECGs in this study should be interpreted at La Manga according to the 
Minnesota Code Classification System for Electrocardiographic Findings, but was as usual left to 
personal experience (16;56). In 2010, the ESCs recommendations for interpretation of 12-lead 
ECG in the athlete were published (16), but detailed definitions of Q waves, axis deviations, right 
ventricular hypertrophy, ST-segment depressions, QT-abnormalities and ventricular extra systoles 
were lacking. In addition minor T wave inversions were not defined, even if the authors 
recommended further follow-up of these. Whether or not these minor alterations are included as 
abnormal ECG findings cannot be read in the paper. Therefore we chose to use Uberoi et al’s 
recommendations for interpreting ECG in young athletes from 2011 since that paper is more 
specific than the ESC criteria from 2010. Seven of the authors contributed to both publications, 
and we therefore regarded Uberoi et al’s paper as specifications to Corrado et al. (57). Finally, in 
the beginning of February 2013, the Seattle criteria for interpreting ECG in athletes were 
published in British Journal of Sports Medicine (58-61). These recommendations were developed 
in collaboration between the American Medical Society for Sports Medicine (AMSSM), the 
Section of Sports Cardiology of the European Association for Cardiovascular Prevention and 
Rehabilitation (EACPR), the FIFA Medical Assessment and Research Center (F-MARC), and the 
Pediatric & Congenital Electrophysiology Society (PACES). The ECGs in our study were 
interpreted as accurately as possible according to the specified ESC recommendations and Seattle 
criteria.  
Echocardiography 
Echocardiography is an important tool when studying the athlete’s heart, which is recognized by 
eccentric symmetrical hypertrophy (thickening of the myocardial wall and increase of left 
ventricular chamber), as opposed to hypertrophic cardiomyopathy, which is usually recognized by 
asymmetrical concentric hypertrophy. Hypertrophy secondary to hypertension and aortic stenosis 
is recognized by concentric symmetrical hypertrophy. The athlete’s heart is therefore not 
involved as a background-cause to sudden death in athletes, in the way congenital cardiac 
diseases, such as cardiomyopathies, are. It is of utmost importance to differentiate between 
physiological and pathological hypertrophy as suggested by Maron et al (62). 
   Echocardiographic evaluations were used as the best available “gold standard” in our project, 
since the Regional Ethical Committee did not allow results from recommended follow-up 
investigations to be part of the present study.  
Introduction 
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   Descriptions of athlete’s heart in Scandinavia are scarce, and with application of new 
technology, as 2-dimensional speckle tracking (2-D Strain) echocardiography, one of the main 
aims of this research project was to contribute to original knowledge of the Norwegian athlete's 
heart, as well as to international understanding of the field. This part of the project constitutes a 
separate PhD thesis, written by Gard Filip Gjerdalen. 
  
Aims of the thesis 
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Aims of the thesis 
 
The general aim was to describe the Norwegian athletes’ heart.  
 
Specific aims 
1. To describe the prevalence of high BP in male professional soccer players and the 
associations of BP to HR, PP, LVmassBSA, LA size and SAC. Secondly, we wanted to 
investigate differences in these parameters between hypertensive versus normotensive 
soccer players, white European players versus controls, and white versus black players. 
(Paper I). 
2. To identify the prevalence of high ABP in male professional soccer players in Norway 
and to examine the players’ compliance to recommended follow-up of high BP. Second, 
we wanted to study if indicators of sympathetic activity were increased in players with 
high BP. (Paper II). 
3. To compare the prevalence of abnormal ECG findings between ESC’s recommendations 
as specified by Uberoi et al, with the new Seattle criteria for interpreting ECG, in male 
professional soccer players in Norway. We also wanted to show how slight differences in 
the criteria would affect our results, and to describe in detail the performance of the ECG 
procedure to facilitate meaningful comparison with other studies. (Paper III). 
4. To compare the prevalence of abnormal ECG findings between visual and computer-
based measurements, according to the ESC’s recommendations as specified by Uberoi et 
al, and the new Seattle criteria for interpreting ECG, in male professional soccer players 
in Norway. The performance of the ECG sampling and visual and computer-based 
measurements are described in detail. (Paper IV).  
  
Materials and Methods 
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Materials and methods 
Participants 
La Manga, Spain 2008 
During the winter 2008, all Norwegian male professional soccer players underwent mandatory 
preparticipation cardiac screening when attending a training camp in La Manga, Spain (2). Players 
aged 18 to 40 years were 
invited to participate in the 
study, while players <18 years 
were excluded due to 
practical challenges with 
collecting parental consent. 
Male controls of the same 
age, exercising three or less 
times per week, were for practical reasons selected among the teams’ staff and the remaining as 
volunteers from the Oslo region. All participants gave informed written consent. The study was 
approved by the Regional Ethical Committee (Paper I- IV).  
 
Norway, 2010/2011 
Based on the players’ BP from the screening in 2008, we 
designed a case-control study and recorded ABP from 
October 2010 until February 2011. All available players with 
untreated high BP (n=37) were assessed for eligibility as 
cases, excluding players living abroad. Controls were 
randomly selected from players with optimal blood pressure 
(n=250) according to a predefined protocol, and individually 
matched for age group (or maximum age difference four 
years), ethnicity and professional soccer team. All participants 
gave informed written consent. The study was approved by 
the Regional Ethical Committee (Paper II).  
Materials and Methods 
 20 
Questionnaire 
Athletes and controls responded to a questonnaire regarding their height and weight, if they used 
snuff every day and if their ethnicity was Caucasian, Afro-American or other. In addition they 
answered whether they had experienced chest pain, palpitations, syncope/near syncope or 
breathlessness during or in close proximity to exercise, and if SCD, CV disease, HT or diabetes 
had occurred in a first-degree relative under the age of 55 years (Paper I&III). 
Athletes who participated in the follow-up study with ABP recordings were asked once again 
about symptoms during or in close proximity to exercise, family history of CV disease and if they 
used snuff every day. In addition they reported if they currently used any medications, if 
something extraordinary had occurred during the recording period, and if they had undergone 
additional OBP or ABP recordings after the screening in 2008 (Paper II).  
 
Paper I, III and IV 
Twenty-eight of the 30 Norwegian elite and 1st division leagues participated in the study, and 595 
of 604 eligible players (99%) consented to participate. The players had a mean age of 25.1±4.5 
years, mean body mass index (BMI) 23.7±1.2 kg/m2 and mean BSA 2.0±0.1 m2. Among the 
players, 493 (83%) were Europeans, 52 (9%) Africans, 29 (5%) Americans, four Asians, four 
Australians, and 13 (2%) were of unknown origin. The skin colour was white in 504 (85%), black 
in 49 (85), mixed for 13 (2%) and other for 29 (5%). BP results were available from 594 players. 
All the 47 included controls were white Europeans (Paper I). ECG of good quality was available 
from 587 players (99%), computerized for 579 and on paper only for eight (Paper III). 
Computerized ECG of good quality for visual and computer-based measurements was available 
from 579 players (97%) (Paper IV). 
 
Paper II 
Twenty-six of the 28 (93%) non-treated hypertensive players (cases) still living in Norway, and 26 
controls were included in this study. Nine were excluded because they were living abroad, two 
because they had hypertension grade II and were on antihypertensive medication, one because he 
never had the time, and one because he did not want to participate. 
Materials and Methods 
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Physical examination 
Office blood pressure 
The examinations were preferably conducted before exercise, and at least one hour rest was 
required. BP was measured after five minutes rest in a sitting position, using a validated automatic 
BP monitor (Dinamap ProCare DPC300N, GE, Milwaukee, USA). Systolic BP (SBP) and 
diastolic BP (DBP) were registered as the mean of two consecutive BP measurements and 
categorized according to European Society of Hypertensions’ guidelines for BP (table 1) (38). 
High BP was defined as SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg. Mean arterial pressure (MAP) 
was defined as DBP + 1/3 (SBP-DBP), PP was calculated as the difference between SBP and 
DBP, and SAC as stroke volume (SV) from the two dimensional echo recordings divided with PP 
(Paper I and II) 
Category Systolic BP (mmHg)  Diastolic BP 
Optimal <120 and <80 
Normal 120 – 129 and/or 80 – 84 
High normal 130 – 139 and/or 85 – 89 
Hypertension grade I 140 – 159 and/or 90 – 99 
Hypertension grade II 160 – 179 and/or 100 – 109 
Isolated systolic HT ≥140 and <90 
 
Ambulatory blood pressure 
On the recording day, the players resigned from snuffing and exercise in the morning and all 
kinds of sport activities for the following 24 hours. Outside this, they engaged in normal activity 
in accordance with the guidelines from the European Society of Cardiology and European 
Society of Hypertensions.(38) The project leader (HMB) measured the upper-arm girth, fastened 
the appropriate cuff to the players’ non-dominant arm, and the ABP device (Tonoport, 
CardioSoft, GE Healthcare, Oslo, Norway) was kept in a belt. The ABP device was programmed 
with software CardioSoft V6.61 to obtain blood pressure readings at 30-minutes intervals from 
7:00 AM until 09:59 PM, and at 60-minutes interval during the night. Nighttime was later 
adjusted for reported time in bed, and daytime the rest of the time. Measurements were 
automatically repeated when registered as not valid (Paper II).  
Table 1. Definitions and classifications of office blood pressure levels. ESC 2013. 
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Data definitions 
Among the 52 players, daytime ambulatory BP monitoring was successfully committed in all 
players, at nighttime in 51 players. The mean valid measurements were 26.9 ± 4.5 and 8.3 ± 3.4 
during the day and night respectively. According to published guidelines, high office BP was 
defined as ≥ 140/90 mm Hg, high ambulatory BP during daytime ≥ 135/85 mm Hg, during 24-
hour ≥ 130/80 mm Hg and during nighttime ≥ 120/75 mm Hg (38;63). We used daytime 
ambulatory BP, which is most common, when the players were categorized in four BP subgroups 
(64) (table 2). 
   After ambulatory BP monitoring, both players with true normotension and white-coat 
hypertension were defined as normotensive players, and both players with masked hypertension 
and sustained hypertension were defined as hypertensive players. 
   Nocturnal dip in BP was defined as a mean 10 % decline in average systolic or diastolic BP at 
night compared to daytime.(65) High HR, (48) increased PP and (49) nighttime ABP, and lack of 
nocturnal dip (65) were considered as indicators of increased sympathetic activity. 
Subgroups Office BP (mmHg)  Daytime BP (mmHg) 
Sustained HT ≥140/90 and/or ≥135/85 
White-coat HT ≥140/90 and/or <135/85 
Normotension <140/90 and <135/85 
Masked HT <140/90 and/or ≥135/85 
Electrocardiography 
With the player supine the precordial ECG electrodes were placed according to 
recommendations (50), and the four limb lead electrodes were placed on the arms and legs just 
distal to the shoulders and hips. ClickECG (Cardiette Cardioline, Milan, Italy) with Real Click 
software version 3.2.10 collected the simultaneous ten seconds digital recordings with front-end 
sampling rate of 2000 per second and compression ratio 4:1. Paper speed was 25 mm/s with 10 
mV gain. The frequency response was 0,05 Hz - 150 Hz, the baseline filter was always on, 
network filter was set at 50 Hz and muscular filter at 40 Hz. The filtered signals were stored. The 
software recognized waveforms with amplitudes of at least 25 μV and durations of at least 6 ms. 
Table 2. Definitions and classifications of blood pressure subgroup levels. 
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Figure 5. Fiducial points and measurements were computed and stored in the measurement table. 
Figure 4. After QRS was detected and classified, a medium beat (red rectangle) for all leads was built from every sinus 
complex. 
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   The visual analysis was performed on 100-400% magnified signals on a 24” screen with 
1680x1050 MPixel resolution, using on-screen callipers (Real Click, software version 3.5.4.): 
  
Figure 6. The averaged PQRST complex in each lead (right) was calculated by the trimmed mean, discarding the first 
and last quartile of the data (left). 
Figure 7. The superimposed global complex (SGC) was composed of 12 representative beats superimposed from each of 
12 leads (left), and durations were measured from the earliest onset to the latest offset in the SGC and stored in the 
database (right). Heart rate in beats per minute (bpm) and QRS axis in degrees were derived from the computer and 
visually confirmed. 
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Figure 9. The R and S wave amplitudes were measured to the nearest 1 μV as the mean of the highest amplitudes in 
the QRS complexes, and the maximum P wave amplitude was measured in lead II. 
Figure 8. The P wave, PR interval and QRS duration were measured to the nearest 2 ms from the average PQRST 
complex in lead II. If the PR interval was <120 ms in lead II, all leads were measured. The PR interval was 
categorized as short if <120 ms in all leads. Intraventricular conduction delay was diagnosed if the QRS duration in 
lead II was >120 ms according to the specified ESC recommendations, or if the computer-derived QRS duration was 
≥140ms after visual assessment of first onset to last offset in the SGC. The offset of the QT interval was adjusted 
visually using the intersection between a tangent drawn from the descending part of the T wave to the horizontal line 
drawn between the PR intervals in lead II, V3 or V5. QTc was defined according to Bazett’s formula and categorized 
as prolonged if ≥470 ms in any lead. The QT duration was visually assessed in all leads if QT was ≤330 ms or QTc 
<340 ms (ESC recommendations), or ≤320 ms (Seattle criteria), and only regarded as short if these criteria were 
fulfilled in all leads. 
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   The following amplitudes were visually assessed and measured with on-screen calipers in the 
separate leads if borderline: ST segment depression was categorized as >0.5 to 1.0 mm or >1.0 
mm in any lateral leads (I, aVL, V5 or V6) and >1.0 mm in any other lead, ST segment elevation 
was categorized as >1.0 mm, pathological T wave inversion as >1.0 mm (or negative part of 
biphasic T wave >1 mm) and pathological Q wave amplitudes as ≥3.0 mm and/or 40 ms in 
duration. All amplitudes were related to the PR line.  
   For detailed differences between the specified ESC recommendations and the Seattle criteria, 
see table 1-3 in supplemental online material, paper IV. 
Echocardiography 
All echocardiographic recordings were performed by 13 cardiologists with a 2.5-MHz transducer 
(Vivid 7 and Vivid i; GE Vingmed Ultrasound AS, Horten, Norway) within 30 minutes after the 
BP and HR measurements. The digital data were transferred to a computer (Dell Optiplex 755) 
for off-line analysis at the core echolab, Oslo University Hospital, Aker, with the software 
EchoPAC (BT08) (GE Vingmed Ultrasound AS, 
Horten, Norway). The echocardiographic recordings 
were performed from standard parasternal long- and 
short-axis and apical views. LV internal dimensions 
(LVID) and posterior wall thicknesses (PWT), and 
LV mass were measured at end diastole as 
recommended by the American Society of 
Echocardiography (66;67), LV mass were calculated 
by the formula of Devereux (66). LV volumes were 
measured by modified Simpson’s rule from biplane 2 
and 4-chamber views (figure 10) (66;68). From these data, SV was calculated. Relative wall 
thickness (RWT) was calculated by 2xPWTd/LVIDd using the parasternal long-axis view (66;69). 
LA size was measured as 
LA end-systolic volume 
(LA ESV) from the apical 
2 and 4-chamber views by 
the method of area-length 
(66). Data regarding 
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chamber quantification were indexed to body surface area (BSA) according to recommendations 
(66) (Paper I&III). 
   The second assessment of echocardiographic analyses during the autumn 2009 were all 
conducted by one of the authors (GFG) who was blinded for the BP results and clinical status of 
the participants (Paper I). 
Interpretation 
On site, experienced cardiologists decided if the players were eligible for professional soccer 
based on their symptoms, family history, physical examination, ECG and echocardiographic 
evaluation (figure 14). After completion of the screening in 2008, three cardiologists reassessed all 
the examinations with remarks and recommended further follow-up. For Paper III and IV, all 
ECGs were assessed and measured by one investigator (HMB), who also developed separate 
syntaxes adjusted to the different criteria, and possible rhythm or conduction disturbances were 
discussed with a cardiac electrophysiologist (KG). The ECGs were categorized as normal, 
including common and training-related ECG changes, or abnormal. (Paper IV). 
 
Adjusted reference values for computer-based measurements 
When the main differences between visual and computer-based measurements were displayed, 
reference values were adjusted for computer-based measurements to obtain better agreement to 
visual analyses (Paper IV).  
Statistical analyses 
All statistical analyses were conducted using SPSS (PASW Statistics 18, IBM Corporation 2010, 
NY, USA) (Paper I, II and III) and (PASW Statistics 21, IBM Corporation 2013, NY, USA) 
(Paper IV). Differences between two subgroups were analyzed using t-tests for continuous 
variables, and χ2 or Fisher’s exact tests for categorical variables. P<0.05 was considered 
statistically significant, and all tests were two-tailed (Paper I, II and III).  
Paper I and II 
Differences in means between all BP categories/subgroups were calculated using analysis of 
variance test for trend for continuous variables, and linear-by-linear analysis for categorical 
variables. The significance levels of differences in means between the subgroups were adjusted by 
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the Bonferroni procedure to control the risk of a type I error. Data are presented as mean ± 
standard deviation or as numbers (percentages).  
 
Paper I 
The players were divided into four subgroups according to their office BP (38). All controls were 
white Europeans, and they were compared to white European players only to make the 
comparisons more homogenous. All white players were compared to all black players, but not to 
players of other or mixed ethnicity, since this category was too heterogeneous. The players were 
also divided according to their position in the team, as goalkeepers or outfield players. Based on 
the match-schedule from La Manga, they were also divided according to whether their team had 
played a match in the evening (4.00 pm or 7.00 pm) the day before their examinations or not.  
   LVID, PWT, LV mass, LA ESV, SV and SAC were all indexed to body surface area (BSA), 
calculated from height and weight. The outcome variables for this study were SBP, DBP, MAP, 
PP, HR, LVIDBSA, PWTBSA, LVMIBSA, RWT, LA ESVBSA, SVBSA and SACBSA. Linear regression 
analysis was used for correlation between two continuous variables. 
 
Paper II 
The outcome variables for this study were mean SBP, DBP, MAP, HR, PP and nocturnal dip in 
systolic and diastolic BP. Correlation between office and daytime ambulatory MAP was tested 
using Pearson’s bivariate correlation analysis. Included cases and controls were compared with 
the remaining players with high and optimal OBP, respectively, to test for selection bias. 
     
Paper III and IV 
Since most of the ECG measurements had non-Gaussian distribution, all data are presented as 
medians and interquartile ranges (IQR), though mean ± standard deviations (SD) are presented 
as online data supplement to make comparisons with other studies easier. 
 
Paper III 
The Mann-Whitney U test was used to test for significant differences between two groups. 
Correlation between QRS duration from the SGC and visual analysis from the average PQRST 
complex in lead II was tested using Pearson’s bivariate correlation analysis. 
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Paper IV 
Intraclass correlations (ICC) were used to test correlations for continuous variables and kappa 
statistics (κ) to test agreement between categorical variables. Intra-observer variability of visual 
analysis according to the Seattle criteria was tested nine months apart from 30 randomly selected 
players. Κ and ICC <0.2 represent poor, 0.21- 0.40 fair, 0.41- 0.60 moderate, 0.61 - 0.80 good 
and >0.8 very good correlation, respectively. Bland-Altman plots were performed between visual 
and computer-based measurements, and all outliers were visually assessed to decide if waves were 
misclassified by the computer.  
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Summary of results 
Paper I 
In this study we investigated the prevalence of high BP (≥140/90 mmHg) in players and 
controls, and in players of white and black ethnicity, and the association between increasing BP in 
groups and LV massBSA, LA volume and arterial compliance. The players’ mean BP was 122/69 ± 
11/8 mmHg. There were no significant differences in prevalence of high BP between all players, 
39 (7%), and controls, 4 (9%), or between white, 32 (7%), and black, 5 (10%), players. There was 
a significant positive linear relationship between BP and LV massBSA, LA ESVBSA, SVBSA, HR and 
PP, and negative relationship to SACBSA.  
 
Paper II 
This study sought to identify the prevalence of high ABP and examine the players’ compliance 
with recommended follow-up of high OBP, and to study if indicators of sympathetic activity 
were increased in players with high BP. The prevalence in BP subgroups is shown in table 3. 
Subgroups Cases (n=26) Subgroups Controls (n=26) 
Sustained HT 15 (58%) Normotension 17 (65%) 
White-coat HT 11 (42%) Masked HT 9 (35%) 
 
Figure 11. One quarter of the players had BP≥130/85 mmHg (left figure). The figure illustrates a significant linear 
relationship between increasing BP category and pulse pressure (right figure). 
Table 3. Prevalence in BP subgroups of cases and controls after office and daytime BP recordings. 
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Mean nighttime ABP was high in 39, and 20 had no nocturnal dip. Ten (38%) of the cases had no 
follow-up of BP. 
 
 
 
 
 
Paper III 
In this study we compared the prevalence of abnormal ECG findings between the ESC’s 
recommendations as specified by Uberoi et al., with the new Seattle criteria for interpreting ECG 
in athletes. We also described the performance of the ECG procedure in detail to facilitate 
meaningful comparisons with other studies. The prevalence of abnormal ECG findings was 
reduced from 29.3% to 11.2% or 66 players by the new Seattle criteria. These 66 athletes were all 
included among the 172 (29.3%) players with abnormal ECGs according to the specified ESC 
recommendations (figure 13). Echocardiography alone 
detected one player with abnormalities. None of the 
players with abnormal ECGs according to the ESC’s 
recommendations only, had abnormal echocardiograms. 
All players, except to with hypertension grade II and LV 
hypertrophy on echocardiography, were found eligible for 
competitive soccer. Based on echocardiographic 
evaluations this reduction increased the specificity of the 
Seattle criteria, without increasing the number of false 
negative ECGs. 
   We also showed that comparisons with previous studies 
were difficult due to imprecise descriptions of ECG 
recordings, analysis methods, and different reference 
values for abnormality in these studies.     
Figure 12. There was a linear relationship between 
increasing BP in the four subgroups and mean 
ambulatory PP (p<0.01). 
Figure 13. Overlapping circles illustrating 
level of agreement of visually abnormal 
ECG findings between the Seattle criteria 
(orange) and the specified ESC 
recommendations (blue). 
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La Manga February to April 2008 
587 players screened with history, physical examination, ECG and echo 
13 different cardiologists decided if  they were eligible to play. 
Temporarily excluded from soccer 
2 players with HT grade II and LVH on 
echo did not get medical clearance. They 
were temporarily restricted from activity 
and received antihypertensive therapy.  
Both continued to play later. 
Medical clearance 
585 players were 
eligible to play. 
Summer 2008 
ECGs from most of  the players were interpreted by 
four cardiologists. Then, echo and/or ECG from 97 
players were reassessed by three cardiologists who 
ended up writing 30 letters recommending further 
investigations, but all players kept their medical 
clearance. 
Recommendations to further investigations: 
Resting ECG (8), new cardiology assessment (14), 24 
hours ECG (8), exercise ECG (9), magnetic 
resonance imaging (5), BP control (6). 
Results of  further investigations?
If  the players underwent recommended follow-up and 
the possible results of  these investigations are 
unknown to us.  
The Regional Ethical Committee did not permit 
access to these results.  
Figure 14. Flow chart explaining assessment of ECG screening results during and after screening in 2008. 
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Paper IV 
This study compared the prevalence of abnormal ECG findings between visual and computer-
based measurements, according both to the European Society of Cardiology’s (ESC) 
recommendations as specified by Uberoi et al, and the new Seattle criteria for interpreting ECG 
in athletes. When the main differences between visual and computer-based measurements were 
displayed, reference values were adjusted for computer-based measurements to obtain better 
agreement to visual analyses. According to the ESC’s recommendations and Seattle criteria 
respectively, ECGs were categorized as abnormal in 171 (29.5%) versus 64 (11.1%) players after 
visual assessments and in 293 (50.6%) versus 127 (21.9%) players after computer-based 
measurements. Agreement between abnormal ECGs according to the Seattle and ESC criteria is 
illustrated in figure 16, and between visual and computerbased measurements with normal 
reference values in figure 17, and with adjusted reference values in figure 18. Intraclass 
correlation was very good for R and S wave amplitudes and moderate to very good for intervals 
(figure 19-20). K was very good for pathological Q wave amplitudes and moderate for T wave 
inversions. 
   Correlations for visual measurements of durations and amplitudes in ECG from 30 randomly 
selected players were very good, except for QRS duration in lead II with ICC 0.621 
(supplementary online table 6). Five ECGs were interpreted abnormal each time according to the 
Seattle criteria (K=1.00). 
   Disagreements mostly regard “borderline” ECG findings without clinical significance, except 
for misclassifications of S as Q waves and vice versa.  
Figure 15. The PR interval in this ECG is between 201 and 220 ms. According to the specified ESC 
recommendations this is defined as a normal finding (PR interval ≤220 ms), and according to the Seattle criteria as a 
training-related finding of first degree atrioventricular block (PR interval >200 ms).  
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Figure 16. Overlapping circles illustrating level of agreement of abnormal ECG findings between the Seattle criteria 
(orange and red) and the specified ESC recommendations (blue and green). 
Figure 18. Overlapping circles illustrating level of agreement between visual and digital measurements after small 
adjustments of computer based reference values. 
Figure 17. Overlapping circles illustrating level of agreement between visual and digital measurements according to the 
Seattle criteria (orange and red) and the specified ESC recommendations (blue and green). 
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Figure 19. Bland-Altman plot of Sokolow-Lyon voltage criteria for LVH (SV1+RV5) in mm. Mean Sokolow-
Lyon: 28.2±8.0 mm. Mean difference: -0.9±2.4 mm. 
Figure 20. Bland-Altman plot of QRS duration in lead II measured by the computer versus visually in ms. Mean 
QRS duration: 101±9.8 ms. Mean difference: -5.1±11.7 ms. 
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Discussion 
Setting and participants 
The Norwegian Football Association (NFF) decided in 2008 that all players in “Tippeligaen” and 
“Adeccoligaen” should undergo cardiac screening in order to receive medical clearance to play 
professional soccer. Two of the teams organized the examinations locally (Tromsø and 
Rosenborg), while the remaining 28 teams were screened during a 1-2 weeks training camp at La 
Manga in Spain. Many soccer players in Norway change team each year, and the level of training 
and organization vary between the clubs. Some of the players have a part-time job or are studying 
in addition to their job as soccer players, while others are “just” playing soccer twice a day. Many 
of the players also have a family and have to follow children to nursery, school and activities. The 
level of stress in every-day life is therefore not limited to how much “play-time” they get, salary 
or new contracts. Some of the players felt that being away from home in Spain was quite relaxing. 
Some of the players who underwent ambulatory BP recordings later reported a higher level of 
stress when they were back in Norway, and that being away from home in Spain was quite 
relaxing. Significantly more players than controls used snuff every day, more than in the general 
population. The first 100 players were asked if they smoked, but this question was canceled, 
when it seemed they all preferred smokeless tobacco.  
   Several other factors related to participants can also influence the results in preparticipation 
cardiac screening studies, and some of them are presented in table 4, and discussed further here. 
 
Age 
Players <18 years of age were excluded due to lack of parental consent. If they had been 
included, we must have considered different reference values for hypertension and abnormal 
ECG findings (70;71). In a huge screening study by Pellicia et al they merged data from all 
athletes (from 8 to 78 years old) and presented an overall prevalence of markedly abnormal (4.8%) 
and abnormal (11.8%) ECGs in 32 652 young amateur athletes (72). The authors acknowledged 
the differences between age groups and presented significantly different prevalence of T wave 
inversions (among abnormal ECG findings) related to age: <20 years; 9.5%, 20-29 years; 38.6%, 
and ≥30 years; 37.9%. Since 84% of our cohort of professional soccer players were 20-34 years 
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old, compared to <30% in Pellicia et al’s study, the overall prevalence of abnormal ECGs was 
higher in our study, with abnormal T wave inversions as the most frequent finding. 
 
Ethnicity 
The options for answers about ethnicity was; “Caucasian”, “Afro-American”, or “other”. Some 
of the answers were obviously wrong. We learned that “Afro-American” means black American 
with African ancestry. Thus, there had been no option for black Africans – from Africa. We 
understood that ethnicity and race are imprecise terms, covering different concepts of nationality, 
religion, migrant status, language, country of birth, family origin and visible physical 
characteristics (73). Therefore, Bhopal recommended that researchers should explain their 
understanding of the concepts of race or ethnicity and the classification they use (73). Among 26 
screening studies presented in table 4, eighteen had no definition of ethnicity, three used self-
assigned questionnaires and five referred to descent. Interestingly, none of these studies describe 
how they define athletes descending from parents with different ethnicity. Since we especially 
wanted to study differences in cardiac adaptations between “Africans” and “Caucasians”, we 
retrospectively defined ethnicity as parents’ homeland and updated the database using internet 
and telephone. We also introduced “mixed” inheritance. 
   Several studies have demonstrated that African/Afro-Caribbean athletes have greater LV wall 
thickness than Caucasian athletes (22;30;74;75), while studies of Arabic athletes has demonstrated 
significantly smaller cardiac dimensions than in Black African and Caucasian athletes (76). In our 
cohort of professional soccer players, Gjerdalen et al showed that LV mass was equally enlarged 
in black and white players, but both left and right ventricular relative wall thickness were 
increased in Africans compared with Caucasian athletes (77). Both LV and right ventricle were 
smaller in Africans than in Caucasian athletes, while left and right atria increased similarly. As a 
consequence of these findings, African athletes had significantly more concentric remodeled LV 
and right ventricle than the Caucasian athletes. Japanese soccer players, on the other hand, 
showed more eccentric remodeling in a study by Kervio et al (78). With regard to distinctly 
abnormal ECG findings, Japanese (10.3%) and Caucasian (6%) soccer players were comparable, 
but differed significantly from African-Caribbean (21%) athletes.  
   A higher prevalence of abnormal ECG patterns in black than white athletes has also been 
demonstrated in highly-trained male American football players (79), in college athletes in Kansas 
(80), and in national level athletes in Qatar (33), among others (75). In Qatar, Riding et al, 
demonstrated a significantly greater prevalence of T wave inversions in black Africans compared 
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to Caucasian and West-Asian athletes (76). A higher prevalence of T wave inversions in black 
(14.3%) compared to white (3.7%) athletes was also shown by Zaidi et al (81). But even when 
anterior T wave inversions were concomitant with marked right ventricular enlargement, 
arrhythmogenic right ventricular cardiomyopathy was never diagnosed in any of these athletes.  
   In our study we found significant differences between black and white players in all 
measurements of durations, except QRS interval, and in half of the amplitude measurements. 
Contrarily, in a study of undergraduate students at Stanford University, no clinical meaningful 
differences between races were demonstrated, although race was not defined (82).  
   We realize that impact of “ethnicity” is very hard to decide, since environmental factors such as 
birthplace and migration also influence the results. Variations in cardiovascular diseases between 
African-born and Caribbean-born black people in New York, for instance, exceeded those 
between black and white people (83).  
    
Sporting discipline and level of physical activity 
Elite soccer players usually run 8-12 km during match play regardless of player position (T, E. 
Andersen, personal communication). Maximal oxygen consumption of players at elite level has 
remained constant for the last 20-30 years, between 60-65 ml/kg/min. However, the number of 
repeated sprints above 25 km/h has increased dramatically over the last decades. 
Hence, physiologists do not regard soccer as a pure endurance sport, but as an intermittent 
intensity sport. Professional American football players who play at positions that require sprinting 
and similar bursts of physical activity associated with abrupt elevations in heart rate, like our 
outfield players, showed more abnormal ECGs than players at positions with lower levels of 
activity (79). And linemen had greater heart mass than other players, despite adjustments for 
body size (84). 
   Several studies have demonstrated the impact of different athletic activity on cardiovascular 
adaptation, as summarized by Pluim et al and Fagard (26;85). Still, the majorities of screening 
studies combine athletes from up to 38 different sporting disciplines together and present one 
common result (table 4). However, even to compare our results with the three other studies of 
only soccer players (table 4), causes concern because of different level of activity, age or ethnicity 
(32;78;86). Since athletes’ hearts develop as a result of athletic activity over time, it is not 
meaningful to compare the prevalence of abnormal findings in our studies including children, and 
where the majority of athletes are entering athletic activity for the first time (72). 
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Controls 
For practical reasons, most of the controls were recruited among the teams’ support people, like 
physiotherapists, coaches and masseurs. They could not be physically active more than 3 h/week, 
but probably they were more fit than the general population because many of them were former 
soccer players. Still, they had significantly higher resting heart rate, and LVmassBSA and LAESVBSA 
were smaller.  
 
Questionnaire 
The players answered the questionnaire before BP recordings. This was the first screening in 
Norway, so they were unaware of questions about self experienced symptoms and cardiovascular 
disease in the family. Some players made extra comments, but in general they were not 
interrogated for their answers by the cardiologists 
   After the screening, three quarter of the players answered another questionnaire, assessing how 
distressed they had been during the screening and how they had experienced the situation (98). 
Sixteen percent were afraid that the screening result might have consequences for their own 
health, and 13% were afraid of losing their license to play soccer. Therefore, underreporting of 
self experienced symptoms or heart disease in the family cannot be excluded. We only asked 
about first degree relatives, while some investigators include second degree relatives (99). 
Relatives were regarded as “young” if < 55 years of age, while the Norwegian guidelines for 
assessment of cardiovascular disease risk extends this to 65 years for women (40). Others only 
ask for a history of SCD in relatives under the age of 35 years (99). 
 
Physical examination 
Height and weight were self-reported, and this might have influenced the echocardiographic 
variables which are indexed to body surface area (BSA). However, for example one centimeter or 
one kilo more or less has minimal impact on LVmassBSA. To illustrate this, a player who reports 
78 kilos and 181 cm, with LV mass 224.7 g, has a calculated LV massBSA at 113.5 g/m2 if the 
reported variables are correct, and 112.7 g/m2 if his real weight were one kilo more, or 113.8 
g/m2 if his real height were one cm less.  
.
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Table 4. Characteristics of participants and settings in studies of preparticipation cardiac 
screening in athletes  
1st author (Ref) Published Country Number of 
participants 
Age, mean 
(median) 
-range 
Maron (87) 1987 US   501 19 17-30 
Bjørnstad (88) 1991 Norway  1299 24 24 
Pellicia (31) 2000 Italy  1005 (23) 9-55 
Choo (89) 2002 US  1282 22 22 
Corrado (15) 2006 Italy 42386 ? 12-35 
Pellicia (72) 2007 Italy 32652 22 (17) 8-78 
Magalski (79) 2008 US  1959 23 20-29 
Basavarajaiah (90) 2008 UK  3500 21 14-35 
Thunenkotter (91) 2009 Germany   582 27 ? 
Baggish (92) 2010 US   510 19 (>18 
Corrado (16) 2010 Italy  1005 (23) 9-55 
Le (29) 2010 US   658 20 ? 
Malhotra (93) 2011 US  1473 19 ? 
Papadakis (30) 2011 UK & France   904 23 14-34 
Magalski (80) 2011 US   964 ? 18-21 
Wilson (33) 2012 Qatar  1220 23 12-35 
Gademan (82) 2012 US   653 20 ? 
Schmied (94) 2012 Switzerland 102 (34) 20-68 
Kervio (78) 2013 Japan & France   282 24 17-35 
Schmied (32) 2013 Gabon   210 19 18-22 
Zaidi (81) 2013 UK   675 22 14-35 
Riding (76) 2013 West Asia  1175 24 13-40 
Brosnan (28) 2013 Australia  1078 20 16-35 
Zaidi (95) 2013 UK   627 22 14-35 
Riding (96) 2013 Qatar  1328 ? ? 
Gati (97) 2013 UK  2550 22 14-35 
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Table 4 continues 
 
Gender Ethnicity Definition 
of ethnicity 
Sport Setting 
Mixed Mixed ? Mixed University of Maryland, athletes 
Mixed ? ? Mixed National Sport College 
Mixed White ? Mixed National team members, Italy 
Males Mixed ? Football National Football League Players 
Mixed ? ? Mixed Competitive athletes, Veneto 
Mixed Italian ? Mixed Young amateur athletes 
Males Mixed ? Football College, athletes 
Mixed Mixed ? Mixed Elite athletes 
Males Mixed ? Soccer World Cup Players, Germany 
Mixed Mixed ? Mixed Harvard University, athletes 
Mixed White ? Mixed National team members, Italy 
Mixed Mixed ? Mixed Stanford undergraduate students 
Mixed Mixed ? Mixed College athletes division I 
Males Black Self-assigned Mixed Athletes, regional to international 
Mixed Mixed ? Mixed University of Kansas, athletes 
Males Mixed Descent Mixed National level athletes 
Mixed Mixed ? Mixed Stanford undergraduate students 
Mixed ? ? Mixed Competitive athletes 
Males Mixed Descent Soccer First league soccer championship 
Males Black Gabonian Soccer Competitive soccer, high level 
Mixed Mixed Self-assigned Mixed Athletes, regional to international  
Males Mixed Descent Mixed National level athletes 
Mixed Mixed Descent Mixed Professional elite athletes 
Mixed Mixed ? Mixed Athletes, regional to international 
? Mixed ? Mixed Athletes exercising ≥6 h/week 
Mixed Mixed Self-assigned Mixed Athletes, regional or national 
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   The IOC Consensus Statement on periodic health evaluation of elite athletes (1) proposes that 
physical examinations should be performed according to best clinical care and should investigate 
the presence of: 
x Musculoskeletal and ocular features suggestive of Marfan syndrome 
x Diminished and delayed femoral artery pulses (co-arctation) 
x Mid-or end-systolic clicks  
x Abnormal second heart sound (single or widely split and fixed with respiration) 
x Heart murmurs (Systolic grade >2/6, and any diastolic) 
x Irregular heart rhythm 
   Players with Marfan’s syndrome are more likely to be found in sports like basketball and 
volleyball, since these sports favor tall players. Average mean height in our study was 183±6 cm, 
and only two players were >200 cm. About 12-20 children are born with Marfan’s syndrome each 
year in Norway, and in 75% of the cases they inherit the condition from one of their parents 
(100). We might debate whether to include stigmata for Marfan’s syndrome in screening in all 
sports disciplines in Norway owing to low incidence and already known disease, but remember 
these athletes might develop serious aorta dissection and even rupture because of weak 
connective tissue. Dilatation of aorta might also lead to aorta regurgitation. High athletic activity 
is not recommended since this might lead to progression of the aortic dilatation. Cardiac 
auscultation was not performed in this screening because all players underwent 
echocardiography. Aortic diameter was not investigated though.  
 
Office blood pressure 
The cardiac examinations of >670 participants were performed during a few weeks, by thirteen 
cardiologists and six nurses. Most often the players exercised twice a day, so it was impossible to 
avoid physical activity prior to the investigations. The minimum time gap between exercise and 
examinations was one hour, but most often several hours.  
   Detailed description of each player’s physical activity was not collected, and retrospectively it 
was only possible to compare players whose team had played a match the day before versus not 
played. No significant difference in BP was found, but there are several limitations to these 
assumptions of the players’ prior activity. We have been questioned whether post exercise 
hypotension can explain a low prevalence of high office BP, and if this also can explain the 
corresponding increased prevalence of high ambulatory BP.   
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   Post exercise hypotension has been known at least since 1898 (101). At that time, Leonard Hill 
of the London Hospital Medical College published the results of a subject who ran 400 yd "as 
rapidly as possible" and had a 10- to 15-mm Hg reduction after 10 min rest, and 30-35 mm Hg 
after 60 min (102). Hill concluded, "The arterial pressure becomes depressed below the normal 
resting pressure after severe muscular work". But still there is no widely accepted normal BP 
response to exercise (103), except for an initial physiologic rise in systolic BP. The magnitude and 
duration (seconds to 20 min) of the immediate post exercise hyperaemia is dependent on the 
time, type and intensity of exercise (104). An exaggerated BP response on the other hand, defined 
as systolic BP >210 mm Hg during a treadmill exercise test in men, might be a predictor of future 
HT (103;105). Diastolic BP, usually unchanged or decreased during exercise, was shown to be an 
independent predictor of masked HT in subjects with exaggerated BP response, and increased 
with 15 mm Hg in patients with masked HT compared to 4 mm Hg in normotensive patients. 
Likewise, an inadequate fall in diastolic nocturnal BP might also be associated with masked HT 
(105). Systolic BP decreases after exercise, but the level and duration of hypotension depends on 
type of exercise (106-108) and pre exercise BP levels (109). Recent laboratory studies have usually 
been conducted in small groups. Keese et al studied in 21 healthy men (mean age 20.7±0.7 years), 
the immediate BP lowering effects of resistance exercise, aerobic exercise, and concurrent 
(resistance and aerobic) exercise for 60 minutes, compared to control (table 5) (108).  
 Decrease in systolic BP Decrease in diastolic BP 
1st author (Ref) / Exercise in mm Hg in min in mm Hg in min 
Keese (108)     
Control, seated rest 60 min     
Resistance*  4.1±2.0 80 1.8±1.1 20 
Aerobic† 65% VO2peak 50 min 6.3±1.3 >120 1.8±1.0 50 
Concurrentǁ 65% VO2peak 20 min 5.1±2.2 >120 1.6±0.6 40 
Keese (106)     
Control, seated rest 60 min     
Concurrentǁ 50% VO2peak 30 min 4.2±2.5 60-70 1.2±0.4 40 
Concurrentǁ 65% VO2peak 30 min 4.8±2.7 >120 1.5±0.6 40 
Concurrentǁ 80% VO2peak 30 min 6.0±2.0 >120 1.8±1.2 60 
 
Table 5. Exercise induced BP reduction in 21 healthy men, mean age 20.7±0.7 years and mean resting BP 
111.5±2.6/73.9±3.6 mm Hg. *Resistance exercise; 3 sets at 80% 1 RM for 8 exercises, including upper and lower 
limb. †Aerobic exercise; cycle ergometer. ǁConcurrent exercise; 2 sets at 80% 1 RM for 6 exercises, plus cycle ergometer. 
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The decrease in systolic and diastolic BP was similar after all exercise sessions and significantly 
different from control. The duration of decreased systolic BP was longer after aerobic and 
concurrent exercise versus resistance exercise, and for diastolic BP after aerobic exercise 
compared to concurrent and resistance exercise (table 5). Then they studied how resistance and 
aerobic concurrent exercise with different intensities influenced post exercise hypotension (106). 
The magnitude of SBP decrease was similar after all concurrent exercise sessions, but the post 
exercise hypotension lasted approximately 1 h longer following the highest intensities (table 5). 
The magnitude of DBP decrease was slightly greater after concurrent exercise at higher intensities 
and longest after concurrent exercise at the highest intensity (table 5). They concluded that 
concurrent exercise sessions elicited post exercise hypotension, especially when the intensity of 
the aerobic exercise was higher than 65% VO2peak. 
   In another small group of eleven healthy prehypertensive subjects (mean age 28.3±8.0 years), 
Bhammar et al studied the effect of fractionized aerobic exercise (3x10 min during 8 h) and 
continuous exercise (1x30 min), versus control, and found that mean systolic 24 h ambulatory BP 
was significantly lower during fractionized training versus control (127 versus 130 mm Hg) (107). 
Both types of exercise reduced the systolic BP during daytime, but only fractionized exercise 
reduced BP during nighttime (118 versus 122 mm Hg). Prehypertensive subjects were defined as 
per Joint National Commission 7 guidelines (110), and were comparable to players with normal 
and high normal BP in our study (table 1). The subjects’ mean BP at baseline was 126±5/72±7 
mm Hg versus 127±6/71±7 mm Hg in the prehypertensive soccer players (n=305). It might be 
that the beneficial BP lowering effect of physical activity in general is more pronounced in people 
not engaged in so vigorous continuous exercise as professional soccer, and that the absence of 
nocturnal dipping in ambulatory BP recordings in 38% of the players, indicates an unfavorable 
effect of vigorous exercise. We are not aware of comparable studies of post exercise hypotension 
in elite athletes, and acknowledge several limitations to these assumptions. Besides, some studies 
do not demonstrate any post exercise hypotension (109;111). In a study of ten normotensive, 
recreationally active young men (mean age 25±1 year), no post exercise hypotension was found 
after four experimental exercise sessions (111). Finally, in a study of 32 participants, reduction in 
BP did not correlate with pre exercise BP, but with peak oxygen uptake and time of day (109). 
The authors concluded that if statistical artefacts (as regression to the mean) were not controlled 
for, the degree of post exercise hypotension could be spuriously exaggerated and mask other 
more important moderators of BP change.  
   Summarized, it was difficult to consider the effect of exercise in the individual soccer players 
during the screening programme, and only two of the 26 screening studies in table 6 describe that  
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Table 6. Description of blood pressure recordings and prevalence of hypertension in 
studies of preparticipation cardiac screening in athletes 
1st author (Ref) BP Prior 
activity 
Position Hypertension 
N (%) 
Definition of HT 
(mmHg) 
Maron (87) Yes ? ? 1 (0.2) Mild systemic HT 
Bjørnstad (88) No ?    
Pellicia (31) No No    
Choo (89) No ?    
Corrado (15) Yes ? ? 202 (0.5) >160/100 repeated 
Pellicia (72) Yes ? ? ? ? 
Magalski (79) No ?    
Basavarajaiah (90) No ?    
Thunenkotter (91) Yes ? ? 12 (2) >140/90  
Baggish (92) Yes ? ? 2 (0.4) Elevated BP 
Corrado (16) No No    
Le (29) No ?    
Malhotra (93) Yes ? ?   
Papadakis (30) Yes ? ? 22 (0.8) Excluded, >140 or 90 
Magalski (80) Yes ? ? ♂(5)/♀(0.6) >140 or >90 repeated 
Wilson (33) Yes ? Supine 10 (0.8)  
Gademan (82) No ?    
Schmied (94) Yes ? ? 2 (1.9) ? 
Kervio (78) No ?    
Schmied (32) Yes ? Supine 4 (1.9) >140 or >90 
Zaidi (81) Yes ? ? ? Excluded, ≥120/80 
Riding (76) Yes ? Supine 17 (1.5) >140, referred to ABP 
Brosnan (28) No ?    
Zaidi (95) Yes ? ? ? Excluded, ≥140/90 
Riding (96) Yes ? ? 16 (1.2) Referred to ABP 
Gati (97) Yes ? ? 12 (0.5) Excluded, ≥140/90 
  
Discussion 
 46 
they tried to avoid physical activity for 24 hours prior to the investigations. We might even argue 
that since professional soccer players are training almost every day, some degree of post exercise 
hypotension is probably representative for their resting BP. 
 
 
   The IOC Consensus Statement recommends that bilateral brachial BP should be measured, on 
more than one reading (1). In a systematic review of BP in athletes, preliminary results from 40 
studies revealed that only one study included BP in both arms (112). In a study among 401 
general practitioners in the UK, three quarters were aware of similar recommendations, but only 
30% agreed to it and 13% adhered to it (113). The main reasons for these recommendations in 
the general population are that different BP between arms could stem from abnormalities (co-
arctation, stenosis, dissection, etc.) (114). In young trained people, differences could also be 
caused by muscles compressing an artery. 
  
Ambulatory blood pressure 
The ambulatory BP recordings were done in a standardized way. To include as many as possible 
(93%), the project leader (HMB) travelled around Norway to meet players. Since we also included 
a 5 minutes’ heart rhythm variability test, the players were not allowed to eat or drink in the 
morning, or to use any snuff. Afterwards they were allowed to use snuff so it mimicked their 
ordinary days. Some players were distressed because of the fasting, but overall, they tolerated the 
procedures very well. 
 
Figure 21. Example from BP recordings in the Nick of Time Foundation’s heart screening at Snohomish Highschool 
in 2012. BP is recorded by emergency staff at the first station for physical examinations, and repeated later if high. 
Discussion 
 47 
 
 
   That ambulatory BP is superior to office BP in predicting cardiovascular outcome was first 
shown in 1983 (115), and was the reason why we wanted to perform ambulatory BP recordings 
in the follow up of players with high office BP. This was not part of the original project protocol, 
but was added when we discovered that only six of the 39 players with high office BP at La 
Manga had been recommended to repeat office BP recordings at home. This is in accordance 
with other screening studies which also pay little attention to BP results. Among the 26 studies 
reported in table 6, BP recordings were mentioned in 16, prevalence of hypertension/high office 
BP reported in twelve, and reference values for high office BP defined only in nine. The 
prevalence varied between 0.2% and 5%, and definitions from ≥120/80 mm Hg to >160/100 
mm Hg. Only two studies (reporting from almost the same population) referred athletes with 
high office BP to ambulatory BP recordings, and none had recorded ambulatory BP in athletes 
with normal office BP. Four studies excluded participants with elevated BP.  
   We designed the study as a case (high office BP) – control (optimal office BP) study.Players 
with optimal office BP were used as controls, because we wanted to test if players with high 
office BP have less heart rate variability than players with normal BP, and also if there are other 
differences between the two groups of otherwise healthy athletes,. Results from these tests are 
not published, but we found no significant differences between the groups, but a trend toward 
increased sympathetic activity in players with high office BP, but not with high ambulatory BP. 
This might indicate different influence of sympathetic activity in high ambulatory BP versus high 
office BP, as previously suggested by Fagard et al (116). 
   The most striking results after ambulatory BP was recorded in the first 20 players was a high 
mean ambulatory BP and lack of nocturnal dip (figure 23). This was a surprising finding, and we 
sought for errors by checking the devices and measuring the players’ upper arm circumference to 
make sure that we had used correct cuffs. 
Figure 22. The common opinion has been that 
office BP is higher than ambulatory BP, and that 
is true for people aged 40-50 years of age, but not 
in the younger population. Adapted from 
Pickering,TG. 2008 J Hypertens. 
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   The term “masked HT” was first defined by Thomas G. Pickering in 2002. The prevalence of 
masked HT has varied in studies published after 2002, especially owing to methodological 
reasons (as discussed in paper II). A recent Pubmed search with MESH term “masked 
hypertension” retrieved 22 studies in 2013, and 16, 14 and one in the preceding years, and zero 
before 2010. In studies published during the last two years the study participants are younger (in 
their 40s) compared to earlier studies (117-119). In one study of white-collar workers split in 
different age groups, the prevalence of masked HT in participants <40 years (n=240) was 14.6% 
(117). For comparison, the prevalence of normotension is 71.7%, white coat HT 2.9% and 
sustained HT 10.9%. These figures confirm our findings that masked HT probably is a bigger 
problem than white coat HT (figure 24). 
 
 
 
   We discussed possible factors associated with high ambulatory BP in paper II. In a recent 
study of 246 healthy young students (mean age 15.7 years), shorter sleep duration was related to 
higher ambulatory BP during 24 h, and during the night in white, but not in black adolescents 
(120). These data are consistent with the hypothesis that the cardiovascular consequences of 
short sleep may begin early (121). Yet another study from 2013 showed that most metabolic risk 
Figure 23. Compared to the small difference 
(<5 mm Hg) between systolic office BP and 
systolic ambulatory BP in a population study of 
adults <40 years of age, the difference is >15 
mm Hg in professional soccer players with 
masked hypertension. 
Figure 24. Estimated prevalence of soccer players 
in the four different BP subgroups. HT; 
hypertension, NT; normotension, SHT; 
sustained HT, WCHT; white coat HT. 
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factors were higher in patients with masked and sustained HT compared to normotensives and 
patients with white coat HT (122). This study also showed that significantly more patients with 
masked HT had LV hypertrophy on ECG, decreased transmitral peak early/atrial (E/A) velocity 
ratio by pulsed Doppler, compared to patients with normotension and white coat HT. Patients 
with masked and sustained HT in another study showed significantly lower early diastolic velocity 
(E’) by tissue Doppler imaging, indicating impaired LV relaxation and significantly higher 
transmitral peak early velocity to early diastolic velocity by tissue Doppler imaging (E/E’) ratios, 
reflecting higher LV filling pressures compared to normotensives (123). We could not 
demonstrate any differences, but these findings were not likely to be found in these professional 
young athletes, and the number of participants in each BP subgroup was also low. Nevertheless, 
in the total cohort we demonstrated a significant linear association between increased BP and LV 
massBSA. Similar associations have been seen in three other studies in athletes (76;124;125). Most 
recently in a study of 132 professional American-style football participants who had BP and LV 
remodeling assessed before and after season (125). Both systolic and diastolic BP increased 
significantly, and 47% met the criteria for prehypertension and 14% hypertension grade I 
postseason (110). The strongest predictors for postseason BP were lineman field position, 
intraseason weight gain, and family history of HT. There was a significant increase in the 
prevalence of concentric LV hypertrophy (2 of 64 [3%] versus 20 of 64 [31%]; P<0.001) among 
linemen, and change in left ventricular mass correlated with intraseason change in systolic BP 
(R=0.46, P<0.001). A high prevalence of HT was also shown among male collegiate football 
athletes in the US (126). Although American-style football is difficult to compare to European 
soccer, we agree with the authors that better strategies for awareness, prevention, and treatment 
are needed. 
   We speculated in Paper I whether athletes with elevated BP have an increased risk of 
developing future atrial fibrillation as result of the combination of pressure and volume overload 
(43). We demonstrated 11% increase in left atrial end systolic volumeBSA from players with 
optimal to high BP. The soccer players had significantly lower heart rate than controls, and 
12.1% had first-degree AV block with PR interval >200 ms (Paper III), both factors associated 
with increased prevalence of lone atrial fibrillation in “the Birkopp study” (43). Low heart rate 
also predicted lone atrial fibrillation in another study of healthy middle-aged men in Norway 
(127). In a systematic review and meta-analysis, the calculated increased risk of atrial fibrillation in 
endurance athletes is five-fold (128). Masked HT might be yet another risk factor for “lone” atrial 
fibrillation, since HT is the most important risk factor for atrial fibrillation (129). But if HT also 
is a risk factor for cardiovascular disease in healthy athletes is unknown, since all studies are 
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conducted in the general population. Maybe the reference values for HT should be adjusted in 
physically active people: without any end organ damage and BP <160/100 mm Hg, a diagnosis of 
HT is without consequences for sports participation (12).  
   In international guidelines for HT published from 2000 to 2012, seven of 13 recommend 
ambulatory BP recordings for suspected masked HT, and nine for assessing nocturnal dipping 
status (130). Different algorithms are proposed for assessment and management of masked HT 
in the general population (131;132). Results from the Masked Hypertension Study, a worksite-
based population study, indicate that ambulatory BP recordings are unnecessary if the office BP 
is optimal (118). This is in contrast to our study where we unmasked high ambulatory BP in 
players with optimal BP. Until new prospectively designed studies of high ambulatory BP in 
athletes are performed, we do not know how to best tackle the possible increased health risk in 
players with masked HT.  
 
Electrocardiography 
Four cardiologists reviewed most of the ECGs recorded at 
La Manga (figure 14), but had no common protocol 
describing how to perform the measurements or exactly 
which criteria to use. This reflects common practice in 
screening studies as shown in table 7. This table presents 
an informal review of screening studies involving ≥100 
athletes with a mean/median age ≥18 years. Looking just at papers published during the last five 
years (2009-2013), only half of the eighteen studies made any descriptions at all of measurement 
methods, and ten different criteria for abnormal ECG findings were applied. In addition to 
different athlete-related variables (table 4), prior screening examinations influence the prevalence 
of abnormal findings. In the much cited Italian study of 1 005 national team members (from 9 to 
55 years and 38 sporting disciplines), many were screened and found eligible for sports before, as 
Italy has had mandatory screening since 1982 (133). This reduces the prevalence of new 
abnormal findings in the largest subgroup. But they also included 220 athletes referred from 
other screening centers due to miscellaneous findings, which increased the prevalence of 
abnormal fidnings in this subgroup (31). Abnormal findings also increase when athletes are 
screened for the first time, as in our study. The overall prevalence of abnormal ECGs in studies 
during the last five years varied from 4.5% to 23% (table 7).  
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   In paper III we discuss how different criteria, factors related to technical specifications of 
the ECG device, and the recording situation influence the results. In paper IV we discuss 
how different measurement methods affect the prevalence of abnormal ECGs. 
 
ECG device and technical specifications  
The type of ECG devices that had been used in the different screening studies, were specified in 
thirteen of eighteen papers from the last five years, and seven different types were used. But none 
of the studies mentioned type or version of software, filter settings or lead placements (table 7). 
The technical specifications vary between software. Our ECG device detected waveforms with 
amplitudes of at least 25 μV and durations of at least 6 ms and compressed the signals 4:1, with 
expressed noise measured as root mean square errors of only 0.16%. Some years ago the 
compression ratio had to be higher because of limited storage capacity (50). This results in more 
noise (low- and high-frequency), and affects the high-frequency components of the ECG most, 
with the potential to alter measurements of Q-wave duration and R-wave amplitude within the 
QRS complexes. How this might influence measurements of findings in athlete’s ECG is not 
investigated, but in the general population it can influence the criteria for myocardial infarction, 
among other diagnoses (134). Noise can be reduced to below 5 μV by incorporating more 
complexes into the representative complex (135). This will allow <10% estimated error in 
deflections of 20 μV. In our program, all digital samples were displayed on screen during the 
measurements, because the pixel-to-sample ratio ≥1.0 (52), and the on-screen callipers marked as 
small differences as 2 ms and 50 μV. Compared to measurements with ruler on ECG paper, 
where the smallest detectable differences are to the nearest 10 ms and 100 μV (figure 25 and 26). 
 
 
Figure 25. This figure illustrates two 
different ways to measure durations: 
with ruler on ECG paper (left), and 
with on screen callipers on the 
superimposed global complex(right). 
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Hence, detection of small deflections as ST depressions >0.5 mm, TWI ≥1.0 mm and Q waves 
≥3.0 mm were made easier and can partly explain the higher prevalence of abnormal TWI and 
pathologic Q waves in our study. In our ECG program, first onset – latest offset of the global 
PQRST complex was demarcated in all leads, but the SGC 
were not visible simultaneously. More modern software 
which makes manual adjustment of the demarcation lines in 
the SGC possible in all leads synchronously will further 
increase accuracy of duration measurements (figure 27). The 
correlation between visual measurement in the averaged 
PQRST complex in lead II and the first onset – latest offset 
of the SGC was moderate, r=0.432, with mean difference 
6.4 ms. 
   Three different filter settings which is meant for 
improving the ECG signal quality while real-time sampling 
and recording are conducted should be described (136): 1) 
Power line/AC filter which remove a very narrow band of 
signal frequency, centered at the power frequency 50 Hz or 
60 Hz, dependent on country. This filter affects the S wave 
area of the QRS complex. 2) Baseline filter which should 
always be on to stabilize the isoelectrical line, but that does not affect the accuracy of the ECG 
signal because of the systems algorithm for removal of internal drifting. 3) Muscle tremor filter 
with selected frequencies between 25 Hz and 50 Hz, which is usually activated during exercise 
ECG tests. Unfortunately, the muscular filter was turned on during ECG recordings in the 
resting position at La Manga, possibly because the investigators relied on settings from the 
company, and were unaware of the implications. But when this filter filters out all high frequency 
signals above the selected frequency, this can reduce the sharp corners of the QRS complexes 
and widen it, and reduce the R wave amplitude by more than 20%. In most modern ECG devices 
Figure 26. This figure illustrates two 
different ways to measure amplitudes: 
with ruler on ECG paper (left), and 
with on-screen callipers in each lead 
(right). 
Figure 27. This figure illustrates how 
measurements of first onset - latest 
offset are displayed in all leads 
simultaneously. This ECG is recorded 
with CardeaScreen, Cardea Associates 
Inc, Seattle, WA, USA. 
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the muscular filters only affects the display of the ECG on the screen, while the unfiltered signals 
are stored. Unfortunately, our device only stored the filtered signals.  
 
Athlete’s position and placement of leads during recording 
Five of the latest 18 screening studies described the athlete’s position during ECG recording, and 
they were in a supine position. Previous studies have shown that the body position during ECG 
recording is important for the axis, QRS voltage, and depth of the Q wave and length of the QT 
interval (137;138).  
   Only one study in table 7 paid attention to the lead placements in their papers (28). In this 
study from Australia they also write that abnormal ECGs or groups of ECGs with unusual 
pattern were repeated with careful lead placement, if possible. We agree that this reflects “real 
world” practice. In our project a meeting was arranged ahead of the screening where correct 
placements were demonstrated. All six nurses responsible for lead placements were trained in 
cardiology departments, while one assistant without prior experience also put on the leads. The 
importance of correct lead placements was illustrated in a study where they deliberately misplaced 
the electrodes 2 cm upward and downward in 15 patients and found significant ECG 
interpretation changes in all patients (139). In half of the patients a >25% change in R wave 
amplitude was produced by only 2 cm vertical displacement and this lead to altered R wave 
progression in 20% of the patients. This can have important implications for diagnosis of 
ventricular hypertrophy. Another experimental study showed important changes in diagnostic 
classification in 6% of the cases when interpreted by the computer, and in 3% when interpreted 
by an expert cardiologist (140). 
   ECGs are usually recorded in a resting situation. The Seattle criteria recommend physical 
activity to check whether long PR interval duration or atrioventricular block is reversible (59;60). 
Corrado et al and Wilson et al defined long PR interval duration as respectively ≥210 ms or >200 
ms following exercise or hyperventilation (15;33). Some of the soccer players were also 
recommended to move around before repeating an ECG, but this was random and not noted on 
the report. The player with bradycardia (31 bpm) had only one ECG recording. Another player 
with second degree atrioventricular block type II on the first recorded ECG had first degree 
atrioventricular block four minutes later. If we want to prospectively study long PR interval and 
bradycardia as risk factors for atrial fibrillation in athletes, the recordings should be categorized 
according to activity. 
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Table 7. Description of factors related to recording, measurement and interpretation of 
ECG in studies of preparticipation cardiac screening in athletes 
1st author (Ref) ECG device Soft-
ware 
Paperspeed 
mm/sec & mm/mV 
Position 
Maron (87) Burdick ek-5A ? ? Supine 
Bjørnstad (88) Siemens Mingograph ? 25 Supine 
Pellicia (31) ? ? ? Supine 
Choo (89) ? ? ? ? 
Corrado (15) ? ? 50 ? 
Pellicia (72) ? ? 25 Supine 
Magalski (79) ? ? 25 Supine 
Basavarajaiah (90) Marquette Hellige ? 25 Supine 
Thunenkotter (91) ? ? ? ? 
Baggish (92) MAC 5500 ? ? ? 
Corrado (16) ? ? ? Supine 
Le (29) Schiller ? ? ? 
Malhotra (93) ? ? ? ? 
Papadakis (30) Marquette/ Philips  ? 25 & 10 ? 
Magalski (80) ? ? 25 Supine 
Wilson (33) COSMED Quark ? ? ? 
Gademan (82) Schiller ? ? ? 
Schmied (94) Schiller AT-101 ? ? ? 
Kervio (78) Mac 1200 ? ? ? 
Schmied (32) Schiller AT-101 ? 25 Supine 
Zaidi (81) MAC 5000/5500  ? ? Supine 
Riding (76) COSMED Quark ? ? ? 
Brosnan (28) ? ? 25 & 10 ? 
Zaidi (95) MAC 5000/5500  ? ? ? 
Riding (96) MAC 5500 ? ? Supine 
Gati (97) Marquette /Philips  ? 25 & 10 ? 
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Table 7 continues  
 
Lead 
placements 
ECG measurements ECG Criteria Abnormal 
ECGs (%) 
Echo* 
? ? Maron 1987 14.2 FU 
? ? Bjørnstad 1991 4.8 None 
? ? Pellicia 2000 14.4 All 
? ? Chou/ Knilans 55.0 None 
? ? Corrado 1979 9.0 FU 
? ? Pellicia 2000 11.8 FU 
? ? Pellicia 2000 4.5 FU 
? Callipers and millimetre ruler Bazett/Sokolow ? All 
? ? ESC 2005 ? All 
? ? ESC 2005 23.1 All 
? ? ESC 2010 11.0 All 
? Digital measurements  Stanford 10.0 FU 
? ? ESC 2005 18.7 FU 
? Each lead with callipers Papadakis 2011 ? All 
? ? Pellicia 2000 10.0 All 
? Measured in each lead ESC 2010+ 9.9 FU 
? Digital measurements ? ? FU 
? ? ESC 2010 ? FU 
? Tracer table Pellicia 2000/ESC 2010 12.1 All 
? ? ESC/Seattle 12.4 All 
? Callipers Zaidi 2013 ? All 
? Measured in each lead ESC 2010+ ? All 
Careful ? ESC 2010 & Seattle 17.3 & 4.5 FU 
? Callipers ESC 2010/2011/Seattle ? All 
? ? Drezner 2012 4.7 All 
? Measured in each lead ESC 2010 13.0 All 
*Echocardiography for all or none participants, or only as recommended follow up (FU) of other 
abnormal screening results.  
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Measurement methods 
In the description of methodology of all the papers in table 7, 23 of 26 papers use the words 
“standard”, “12-lead” or “standard 12-lead” ECG. Only two authors (81;90) have a reference to 
this standard: “the variables were measured in each lead using callipers and a millimeter ruler as 
described elsewhere”, that goes back to a book by Friedmann from 1971 (141). This “standard” 
is probably not standard any longer, but how it has changed and how this influences the results 
of measurements is impossible to say. 
   We chose to relate all measurements of amplitudes to the PR line. A different baseline could 
have influenced the results in both directions (figure 28-30). 
  
 
 
 
 
 
Figure 28. This figure illustrates that the ST segments are depressed >1.0 mm in lead aVR when the PR line (upper 
red line) is referred to as the isoelectrical line, and not if the TP segment (blue dotted line) is referred to.  
Figure 29. This figure illustrates that the ST segments are depressed >0.5 mm in lead II whether the PR line (upper 
red line) or the TP segment (blue dotted line) is referred to as the isoelectrical line. But the maximum P wave amplitude 
indicates right atrial enlargement only when the PR line is referred to.  
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These figures illustrate how important it is to describe how measurements of amplitudes are 
performed in a study. The same is true for measurements of durations (figure 25, 27, 31). 
Computer-based measurements of P waves and PR interval durations were missing from 42 
players because of irregular rhythm. In a recent study of 5 757 men and women aged 40 years and 
older, Soliman et al evaluated PR interval dependence on heart rate and found a statistically 
significant interaction between PR and heart rate with age (142). They produced a formula to 
make the PR interval independent of heart rate: PRa = PR+0.26 (heart rate-70). In the age group 
40-60 years, they found that a reasonable threshold for defining first degree atrioventricular block 
would be 220 ms (98th percentile), with 205 ms as borderline reference value (95th percentile). 
This formula has to be tested in younger populations where the factor for adjustment (0.26) 
probably will be smaller. It’s also worth mentioning that the PR interval might vary with 10 ms 
when heart rate is < 45 or >90 bpm, and that differences between softwares might be up to 20 
and 25 ms (142). 
   The most challenging with measurements of duration was to decide where to end the QRS 
complex. In a comment to where to draw the line, professor Frölicher wrote: “Early 
repolarization redux: the devil is in the methods”. The QRS end is also the beginning of the ST 
segment, where early repolarization is measured as the height at this point (143). To make this 
even more confusing, early repolarization changes are described as either elevation of the QRS 
ST junction, ST elevation, J point elevation, J waves, or increase from baseline (PR-line). Not to 
wonder that the prevalence range from 14.3% in Pellicia et al, to 79% in black athletes in Wilson 
et al (supplemental table 9, Paper III) (31;33). ST elevations above 2 mm is mentioned as 
Figure 30. This figure illustrates yet another baseline for measurement of P wave amplitudes. It refers to the 
interpoloated line between P on and P off.  
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uncommon by Uberoi et al, but not included as an abnormal finding.(57) In the professional 
soccer players, 30% had ST elevation ≥2 mm, but this was regarded as a normal finding. The 
association with higher median HR in these players, 57 bpm versus 54 bpm (unpublished data), 
might indicate though that this is not a training-related alteration. 
   In a study of QTc time related to positions, Pressler et al used computer-derived measurements 
(137). To make diagnostic statements on reference values down to <10 ms was not possible 
before. In our study we found very good correlation (r=0.934 to 0.971) between QT interval 
duration measured in lead II, V3 or V5 respectively, with median QT interval duration two ms 
longer in lead II. This fits well with the recommendations to measure the longest QT interval, 
with a preference for lead II (144). We used a semi automated method and adjusted the fiducial 
points placed by an automated algorithm (52). Improved algorithms offered now by several 
manufacturers actually allow them to be used as the primary measurement tool (144). 
 
 
 
 
Criteria 
The ESC recommendations lack the necessary details, and we therefore applied Uberoi et al’s 
definitions of abnormality, which are based on the ESC’s recommendations. In a study that 
compared these two sets of criteria (145), the authors found 19.7% abnormal ECGs applying 
strictly the ESC 2010 recommendations, and 3.9% applying Uberoi et al’s criteria. Compared to 
these findings we have probably not underreported abnormal findings when we chose Uberoi et 
Figure 31. The left figure illustrate that QRS interval is 128 ms when the computer has placed the callipers to measure 
durations in the superimposed global PQRST complex in lead II. With manually adjusted callipers in the right figure, 
the QRS duration is 96 ms. For comparison, the measurement table for this player is displayed in figure 5, showing 
that medium QRS duration in lead II is 112 ms . 
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als’ specifications which reduced abnormal ECGs with 80% compared to the ESC 2010 
recommendations (145). Based on echocardiographic evaluations this reduction increased the 
specificity of the Seattle criteria, without increasing the number of false negative ECGs. 
   The need for different criteria related to black and white athletes is already described, but 
Riding et al found no difference in the frequency of uncommon and training-unrelated ECGs 
between Arabic and Caucasian athletes, and concluded that the ESC guidelines are clinically 
relevant and acceptable for use within Arabic athletes (76). 
   How to define the different abnormalities is described in many ways (supplemental online table 
10, paper III). The criteria for pathologic T wave inversions are described as; ≥-0.1 mV to ≥-0.2 
mV in two, or in two contiguous leads, or in all leads (or in predefined groups of leads), or in all 
leads except in leads V1, V2, aVR or III. Pathologic Q waves are described as either ≥2 mm in 
depth in ≥2 leads, or ≥4 mm in depth in one, or ≥4 mm in ≥2 contiguous leads, or ≥25% of the 
height of the ensuing R wave, or ≥40 ms duration, or the latter in combination with QS pattern 
in ≥2 leads. The prevalence of abnormal ECG findings changes accordingly, as presented in 
supplemental online table 9, paper III. What impact these disparities would have had on the 
prevalence of abnormal ECG findings in our study is presented in supplemental online table 8, 
paper III. 
   There are reasons to believe that the ESC criteria can be simplified without loss of accuracy. 
Zaidi et al compared right ventricular hypertrophy on ECG between healthy athletes, healthy 
controls, patients with established arrhythmogenic right ventricular hypertrophy and patients with 
pulmonary hypertension (95), and found that the Sokolow Lyon voltage criteria for right 
ventricular hypertrophy are frequently fulfilled in healthy athletes without underlying RV 
pathology (on echocardiography or magnetic resonance imaging). They concluded that such 
findings should not prompt further evaluation if observed in isolation, because all patients had 
additional ECG abnormalities. In another study, Gati et al, compared isolated axis deviation and 
atrial enlargement in 2 533 athletes compared to 9 997 asymptomatic controls (97) and 
demonstrated that these two abnormalities comprised 5.5% of the abnormal findings in athletes, 
compared to 4.4% in the controls (p=0.023). No major structural or functional abnormalities 
were identified in any of them on echocardiography. As a consequence they suggested that these 
abnormalities should be excluded by the ESC guidelines. This was supported in an editorial by 
Corrado et al (146). 
   The Seattle criteria represent yet another set of recommendations for interpretation of athletes’ 
ECGs. It is unfortunate to have different recommendations, and several members of the expert 
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panels are common to all three panels, so one possibility would be to improve the Seattle criteria, 
which were based on international consensus. The Seattle criteria have also been presented as 
three free learning modules in the British Journal of Medicine (147), and by the end of February 
2014, over 7,300 modules have been completed by physicians from 93 countries around the 
world. Drezner et al recently showed that application of a standardized ECG criteria tool 
significantly improved the ability to interpret athlete’s ECG across physician specialties (148). 
 
ECG results versus echocardiography 
Hypertrophic cardiomyopathy is the most common cause of SCD in athletes in the US (4). In the 
general young population the prevalence of hypertrophic cardiomyopathy is 0.2% (149). With 
similar prevalence in athletes we would expect to discover two athletes per 1 000 athletes 
screened. However, the observed number of cases is lower. Possibly reasons for this observation 
can be that adolescents with symptoms have withdrawn from sports at an earlier age, athletes 
with disease have been excluded during earlier screening situations, or because of failure to detect 
those with disease, e.g. due to atypical hypertrophic cardiomyopathy. There were for instance no 
athletes with hypertrophic cardiomyopathy after screening 1 078 athletes in Australia, 4 450 
young athletes in Italy, 3 500 elite athletes in the UK or 1 473 college athletes in the US 
(28;90;93;150). Only one fifth of the college athletes had echocardiography, but since ECG in an 
early study by Corrado et al was found to be highly sensitive for hypertrophic cardiomyopathy, no 
false negative findings were suspected (5). But since the mean age of the college athletes was 19 
years, the prevalence could have increased with age, since phenotypic hypertrophic 
cardiomyopathy can be unmasked with age (151). In our study, one player had concentric 
hypertrophy discovered only on echocardiography. He kept his medical clearance, but was 
recommended follow-up with magnetic resonance imaging. In a recent study, patients with 
hypertrophic cardiomyopathy, who had normal ECG or only LV hypertrophy on ECG, had less 
serious phenotype and no events during follow up (152). These observations support the 
presumptions that isolated QRS voltage criteria can be viewed as normal (152). 
   T wave inversions were the most common abnormal ECG finding in our study. Marked 
ventricular repolarization abnormalities can disappear after a detraining period, but case reports 
indicate that these changes are not only training related, but can be a marker of an underlying 
disease resulting in cardiomyopathies, SCA or SCD (30;153-155). Therefore, soccer players with 
T wave inversions should be recommended repeated investigations to detect changes suggestive 
of cardiomyopathy.  
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Conclusions 
x Although the prevalence of high blood pressure in professional soccer players was low, 
our data indicates that there is an association between elevated blood pressure and 
reduced arterial compliance, increased left ventricle mass and left atrium volume even in 
young athletes. This emphasizes the importance of blood pressure measurements and 
standardized follow-up after preparticipation screening of athletes. 
x More than one third of players with optimal OBP had high ambulatory BP, which is a 
novel finding in athletes. High PP and nighttime ambulatory BP, and lack of nocturnal 
dip suggest that professional soccer players have an increased sympathetic activity. These 
players might have an increased risk for CV disease. Follow-up of high OBP after 
preparticipation screening is often random and should be organized.  
x The new Seattle criteria reduced the number of athletes with abnormal ECGs 
considerably compared to the specified European Society of Cardiology’s (ESC) 
recommendations. Based on echocardiographic evaluations this reduction increased the 
specificity of the Seattle criteria, without increasing the number of false negative ECGs. 
Echocardiography in isolation seemed to be of limited value. To compare prevalences 
between studies, proper standardization of methods is still needed. 
x Abnormal ECGs were more than twice as common after computer-based versus visual 
measurements. Agreement between visual versus computer-based findings was better for 
the Seattle criteria than for the ESC’ recommendations. Reference values for abnormality 
might be adjusted depending on measurement methods. Computer-based interpretations 
of abnormality according to the Seattle criteria might be reliable without further 
assessment by a physician.  
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Perspectives 
The main aim of this project was to describe the Norwegian athlete’s heart. Secondarily, we 
wanted to get experience with preparticipation cardiac screening, and ultimately we hoped to 
prevent sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in professional soccer 
players. In a recent review of evidence for cardiac screening in young athletes, Stokstad et al 
found that recommendations in favor of screening are based on studies of limited quality and on 
the personal opinion of experts (156). In a retrospective study of sports-related SCDs in Norway, 
myocardial infarction was reported as cause in 11 of 22 cases (157). If the coronary 
atherosclerotic process is asymptomatic, this will not be detected on routine screening, with or 
without resting ECG. Exercise ECG, with the potential to indicate coronary disease, was 
included in preparticipation cardiac screening before the FIFA World Cup in Germany in 2006, 
but the diagnostic value was limited, because the majority of tests were terminated before the 
athletes reached their maximum exercise capacity (91). Multidetector computer tomography is 
currently the best non-invasive diagnostic tool to detect coronary disease, but is not an option in 
routine screening owing to availability, costs, and radiation (158). Echocardiography in isolation 
has failed to identify additional cardiomyopathies in many screening studies, but is still 
mandatory. If modern ECG devices use the algorithms for interpretation of abnormal ECG 
findings according to the Seattle criteria, echocardiography seems unnecessary in athletes with 
normal findings. ECG algorithms that are specific for athlete characteristics, such as age, ethnicity 
and sporting disciplines, will increase the usefulness of ECG by avoiding misclassifications of 
normal training-related findings as abnormal. The ECG device CardeaScreen (Cardea Associates 
Inc, Seattle, WA, USA) is developed for interpretation of ECG in athletes. Data can be stored 
anonymously online and by pooling databases it might be possible to make new reference values 
for abnormal ECG findings depending on age, ethnicity and sporting disciplines. Abnormal T 
wave inversions were the most common finding in our study, and players with marked 
repolarization changes should be followed, even if the initial examinations are normal. Such 
changes might be an early marker of cardiomyopathy. To be able to compare results from 
different studies, we need proper descriptions of methodology, definitions of ethnicity, and new 
“standards”.  
   Follow up of high office BP after cardiac screening was not systematic in our study, as in most 
other studies. The associations between elevated office BP and reduced arterial compliance, 
increased left ventricle mass and left atrium volume revealed that high office BP is probably not 
an innocent condition even in young athletes, and should be followed up according to the 
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standards of best clinical care. If office BP remains high after standard recordings, ambulatory BP 
should be measured. To learn more about the prevalence of masked hypertension and its 
potential role as cardiovascular risk factor in athletes, we need large prospective studies. 
   The highest incidence of SCA/SCD has recently been demonstrated in black African elite 
basketball players (1/3100 athletes per year) in a high quality study among National Collegiate 
Athletic Association student athletes in the US (159). This in contrast to a study of high school 
athletes in Minnesota, where the incidence based on various sources was 0.7/100 000 person 
years, but still highest in basketball players (160). From the last study, the authors calculated that 
only 2 of 1 000 000 athletes/year could be reliably detected by screening. We know from public 
media reports that some of the Norwegian soccer players have had cardiac disease or suffered 
SCA after the cardiac screening at La Manga, and it therefore seems that screening did not 
prevent SCA. However, SCD was prevented because the players were aware of symptoms and 
sought medical attendance in time, and because cardiopulmonary resuscitation was started 
immediately and automated external defibrillators were available. The importance of first-
responder treatment on the field was also demonstrated in a study from the National Registry for 
use of automated external defibrillators in sports, where 16 (89%) of 18 students athletes who 
had cardiac arrest during physical activity survived (161). SCA during activity has just been 
included in the National Registry for Cardiac Arrest in Norway (162), and this is fundamental for 
quantification of these incidents, and for learning if they are preventable. Currently, the best 
strategy is “hands-on” education in cardiopulmonary resuscitation, and increased availability of 
automated external defibrillators. That children in Norway inhibit the Guinness World record in 
CPR is promising for the future! 
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Abstract 
Background 
Abnormal ECG findings are important reasons for follow-up investigations after preparticipation cardiac 
screening in athletes. The main aim of this study was to compare the prevalence of abnormal ECG findings in 
athletes according to European Society of Cardiology’s (ESC) recommendations and the Seattle criteria.  
Methods and Results 
A Norwegian preparticipation cardiac screening of male professional soccer players in 2008 enrolled BP, ECGs 
and echocardiography from 587 of 595 (99%) players (mean age 25 years, range 18-38). ECG was recorded 
with ClickECG, and measurements were derived with visually adjusted on-screen callipers on the computer-
based averaged PQRST complex. The echocardiographic recordings were performed with Vivid 7 and Vivid i 
and categorised according to reference values for athlete’s heart. Three cardiologists recommended follow-up 
after the initial screening. All ECGs were later interpreted according to both the ESC’s recommendations and 
the Seattle criteria. In total 32 (5.5%) players were initially recommended follow-up. The prevalence of 
abnormal ECGs was 29.3% versus 11.2% according to the ESC’s recommendations and the Seattle criteria, 
respectively. Echocardiography alone detected one player with abnormalities. None of the players with 
abnormal ECGs according to the ESC’s recommendations only, had abnormal echocardiograms.  
Conclusions  
The Seattle criteria reduced the number of athletes with abnormal ECGs considerably compared to the ESC 
recommendations. Based on echocardiographic evaluations this reduction increased the specificity of the 
Seattle criteria, without increasing the number of false negative ECGs. 
  
Keywords: ECG criteria; screening; electrocardiography; echocardiography, sudden cardiac death 
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ECG has a low sensitivity and specificity to detect potentially lethal cardiac disorders in athletes, speaking 
against its inclusion in preparticipation cardiac screening.1 Application of the recently published Seattle criteria 
for interpreting ECG in athletes will lead to a reduction in abnormal ECG findings by categorizing more 
commonly found alterations as normal.2  
   The prevalence of abnormal ECG findings relates to age, gender, ethnicity, level of activity and sporting 
discipline.3-8 Prior participation in screening will also influence the prevalence. However, many studies compile 
all results despite a heterogeneous population.9;10 In order to identify ECG findings that may discriminate 
normal from pathological remodeling, we need standards comprising all phases of the ECG recording, 
processing and interpretation. The ECG devices’ technical specifications, lead placements and methods for 
measurement can all result in significant differences in the reported amplitudes, intervals and diagnostic 
statements.11;12 However, such information is rarely presented.12  
   During the last decade, ECG devices with built-in algorithms for measuring intervals from earliest wave onset 
to latest offset in all leads have become more utilized, and must be accounted for in comparative studies.12 
   Hence, the main aim of this study was to compare the prevalence of abnormal ECG findings between the 
European Society of Cardiology’s (ESC) recommendations as specified by Uberoi et al, with the new Seattle 
criteria for interpreting ECG, in professional soccer players in Norway.2;13 The performance of the ECG 
procedure is described in detail to facilitate meaningful comparison with other studies.  
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Methods 
Participants 
595 male professional soccer players in Norway underwent mandatory preparticipation cardiac screening 
during a preseason training camp in 2008.14 Players aged 18 to 40 years responded to a questionnaire 
regarding their height, weight, ethnicity (Caucasian (white), Afro-American (black) or other), whether they had 
experienced symptoms during or in close proximity to exercise (table 1), and about cardiovascular disease in 
first-degree relatives <55 years (table 1). All participants gave informed written consent, and the study was 
approved by the Regional Ethical Committee.  
 
Physical examination 
Sitting blood pressure (BP) was registered after at least one hour rest as the mean of two consecutive BP 
measurements from a validated automatic BP monitor (Dinamap ProCare DPC300N, GE, Milwaukee, USA), and 
categorised as high BP when systolic BP (SBP) ≥ 140 mm Hg or diastolic BP (DBP) ≥ 90 mm Hg.  
 
Electrocardiography 
With the player in a supine position, the precordial ECG electrodes were placed according to 
recommendations,12 and the four limb lead electrodes were placed on the arms and legs just distal to the 
shoulders and hips . ClickECG (Cardiette Cardioline, Milan, Italy) with Real Click software version 3.2.10 
collected the simultaneous ten seconds digital recordings with a front-end sampling rate of 2000 per second 
and compression ratio 4:1. Paper speed was 25 mm/s with 10 mV gain. The frequency response was 0.05 Hz - 
150 Hz, the baseline filter was always on, network filter was set at 50 Hz and muscular filter at 40 Hz. The 
software recognized waveforms with amplitudes of at least 25 μV and durations of at least 6 ms. The average 
PQRST complex in each lead was calculated by the trimmed mean, discarding the first and last quartile of the 
data. The superimposed global complex (SGC) was composed of 12 representative beats superimposed from 
12 leads (figure 1), and the duration of the QRS interval was measured from the earliest wave onset to the 
latest offset in the SGC. According to the Seattle criteria, intraventricular conduction was categorised as 
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abnormal if the computer-derived QRS interval duration was ≥140ms after visual assessment of first onset and 
latest offset in all leads in the SGC.  
   The visual analysis was performed on 100- 400% magnified signals on a 24” screen with 1680x1050 MPixel 
resolution, using on-screen callipers (Real Click, software version 3.5.4.): The P wave, PR interval and QRS 
durations were measured to the nearest 2 ms from the averaged PQRST complex in lead II. If the PR interval 
was <120 ms in lead II, all leads were measured, and the PR interval was categorised as short if <120 ms in all 
leads. The R and S wave amplitudes were measured to the nearest 1 μV as the mean of the highest amplitudes 
in the QRS complexes, and the maximum P wave amplitude was measured in lead II. The offset of the QT 
interval was adjusted visually using the intersection between a tangent drawn from the descending part of the 
T wave to the horizontal line drawn from the PR interval in lead II. QTc was defined according to Bazett’s 
formula and categorised as long if ≥470 ms in any lead. The QT duration was visually assessed in all leads if 
≤330 ms or QTc <340 ms (ESC criteria), or QTc ≤320 ms (Seattle criteria), and only regarded as short if these 
criteria were fulfilled in all leads. The following amplitudes were visually assessed on-screen in the precordial 
leads and limb leads, and measured with on-screen calipers in the separate leads if borderline: ST segment 
depression was categorised as >0.5 to 1.0 mm or >1.0 mm in any lateral leads (I, aVL, V5 or V6) and >1.0 mm in 
any other lead, ST segment elevation was categorised as >1.0 mm to 2.0 mm or >2.0 mm, pathological T wave 
inversion as >1.0 mm or >2.0 mm (or negative part of biphasic T wave >1 mm) and pathological Q wave 
amplitudes as ≥3.0 mm and/or 40 ms in duration. All amplitudes were related to the PR line.  
   Heart rate in beats per minute (bpm) and QRS axis in degrees were derived from the computer and visually 
confirmed.  
   For detailed differences between the specified ESC recommendations and the Seattle criteria, see table 1-3 
in supplemental data online. 
 
Echocardiography 
All echocardiographic recordings were performed with a 2.5-MHz transducer (Vivid 7 and Vivid i; GE Vingmed 
Ultrasound AS, Horten, Norway) as described previously.11  
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Interpretations and follow-up 
On site, experienced cardiologists decided if the players were eligible for professional soccer based on history, 
BP, ECG and echocardiographic evaluation. After consensus, three cardiologists recommended additional 
follow-up based on best clinical judgment at that time. For the present study, all ECGs were assessed and 
measured by one investigator (HMB), who also developed separate syntaxes adjusted to the different criteria, 
and possible rhythm or conduction disturbances were discussed with a cardiac electrophysiologist (KG). The 
ECGs were categorised as normal, including common and training-related ECG changes, or as abnormal. 
 
Statistical analyses 
Since most of the ECG measurements had non-Gaussian distribution, data are presented as medians and 
interquartile ranges (IQR). The Mann-Whitney U test was used to test for significant differences between two 
groups. Correlation between QRS duration from the SGC and visual analysis from the average PQRST complex 
in lead II was tested using Pearson’s bivariate correlation analysis. Differences between two subgroups were 
analyzed using t-tests for continuous variables, and χ2 or Fisher’s exact tests for categorical variables. P<0.05 
was considered statistically significant, and all tests were two-tailed. All statistical analyses were conducted 
using SPSS (PASW Statistics 18; IBM Corporation 2010, New York, USA).  
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Results 
ECG of good quality was available from 587 players (99%) of 595 players. Their median age was 25.0 years 
(21.0-28.0), height 183.0 cm (179-187) and weight 79.0 kg (74.0-84.0). The skin color was white in 497 (85%), 
black in 48 (8%), mixed for 13 (2%) and other for 29 (5%). History of symptoms during sports activity and 
cardiovascular disease in first-degree relatives are presented in table 1 and there were no significant 
differences in these between players with abnormal versus normal ECGs. Median office BP was 121/69 mm Hg 
(115.0-128.5/64.0-74.5) and 39 (7%) players had high BPs.  
 
ECG findings according to the ESC and Seattle criteria 
Abnormal findings were present in 172 (29.3%) players’ ECG according to the specified ESC 
recommendations,13 including all the 66 (11.2%) players with abnormal ECGs according to the Seattle criteria 
(figure 2) (see online-only Data Supplement).2 The main differences were accounted for by the reduction in T-
wave inversion (-7.1%), right atrial enlargement (-5.6%), right ventricular hypertrophy (-4.5%) and 
intraventricular conduction abnormalities (-3.9%) (figure 2). Common and training-related findings were found 
in 382 (65.1%) and 512 (87.2%) players according to the specified ESC recommendations and Seattle criteria, 
respectively. The increased prevalence was mainly driven by more incomplete right bundle branch block 
(+7.5%) and first-degree AV block (+7.0%) (see online-only Data Supplement). 
   The median QRS axis was 78.5° (64.0-88.8). The median QRS duration of the SGC and the average PQRST 
complex in lead II was 110 ms (100-120) and 104 ms (98-108), respectively, and they correlated moderately, 
r=0.43 (p<0.0001). For visually analyzed intervals and amplitudes, see table 7 in supplemental data online. 
After visual assessment, four out of seven ECGs with computer derived QRS duration of ≥140ms in the SCG 
were categorised as showing abnormal non-specific intraventricular conduction delay. One of twelve ECGs 
with short PR interval in lead II had short PR interval in all leads.  
 
Recommended follow-up  
After the initial assessment 593 (99.7%) players were found eligible for competitive soccer while two were 
temporarily excluded due to hypertension grade II (≥160/95 mmHg) and left ventricle hypertrophy (LVH) on 
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echocardiography. One of them had abnormal ECG findings according to both criteria, while the other had a 
normal ECG. Two players were already under medical attention when the screening was performed (Wolff-
Parkinson-White (n=1) and idioventricular escape rhythm (n=1)). After the second assessment, another 28 
players received letters with recommendations for follow-up due to: abnormal ECG findings (n=13), high BP 
(n=4), valve insufficiencies (n=9), concentric hypertrophy (n=2), atrium septum aneurism (n=1), or 
combinations of these. One of the players with concentric hypertrophy was detected through 
echocardiography only, though his heart rate was borderline; 31 bpm. Six of the 28 players were 
recommended follow-up due to causes later considered normal and training-related (Mobitz type I second 
degree AV block (n=2), ectopic atrial rhythm (n=2), junctional escape rhythm (n=1) and moderate eccentric 
hypertrophy (n=1)). 
   If recommendations for follow-up should be based solely on abnormal ECG findings and high BP, 194 (33%) 
versus 88 (15%) of the players would have been recommended follow-up according to the specified ESC 
recommendations and Seattle criteria, respectively (figure 3). Echocardiograms in all players with abnormal 
ECG findings according to the ESC recommendations only, were normal. Nine players with normal ECGs and 
valve insufficiencies grade I-II (n=8), atrium septum aneurism (n=1) and the one with concentric hypertrophy 
would have been missed without echocardiography of all players. 
 
Other findings 
Table 8 online relates the present prevalence of abnormal findings to other studies: T-wave inversions and ST 
elevations ≥1 or 2 mm divided in different groups, Q waves categorised as 25% of the ensuing R wave or ≥4 
mm in ≥two leads, and LVH with associated nonvoltage criteria. 
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Discussion 
The prevalence of abnormal ECGs in professional soccer players in Norway was reduced from 29.3% to 11.2% 
when the specified ESC recommendations were substituted by the new Seattle criteria. The main differences 
were accounted for by the reduction in T-wave inversion, right atrial enlargement, right ventricular 
hypertrophy and intraventricular conduction abnormalities (figure 2). Using the Seattle criteria, common and 
training-related ECG changes increased from 65.1% to 83.8%, mainly driven by an increased prevalence of 
incomplete right bundle branch block and first-degree AV block. Only one case of concentric hypertrophy was 
diagnosed by echocardiography alone, and all players with abnormal ECGs according to the ESC’s 
recommendations only, were normal. 
 
ECG findings according to the ESC and Seattle criteria 
The great benefit of the new Seattle criteria is their detailed description of each ECG finding with 
corresponding reference value for abnormality and recommended follow-up.2 Hence, comparison with other 
studies is simplified. In a recent study applying the new Seattle criteria on 16-35 years old Australian elite 
athletes of both sexes, recruited from >15 sporting disciplines, Brosnan et al. found 4.5% with abnormal 
ECGs.15 We found more than twice as many abnormal ECGs using the same criteria.  There are several 
explanations for this. First, our athletic population consisted only of men playing soccer, both factors 
associated with more abnormal ECG findings.10 Second, body position or exact placement of ECG electrodes 
are not reported by Brosnan et al., nor are specifications of their ECG device. The ECG device’s technical 
specifications, software, printed paper output and screen resolutions are all factors that influence the final 
result.11;12 The muscular filter setting to 40 Hz in our study may have broadened the QRS complexes. Manual 
ECG ruler without magnifier measures only to the nearest 10 ms and 0.1 mV. In our study all digital samples 
were displayed, and the on-screen callipers measured durations and amplitudes down to 2 ms and 0.05 mV, 
respectively. Hence, small deflections as T-wave inversions ≥1.0 mm and Q waves ≥3.0 mm were easier to 
detect.11 Third, the visual assessment both on paper and on-screen has subjective components: where to start 
and end a measurement and in choice of lead. The correlation between visual analyses of the QRS duration in 
the average PQRST complex in lead II and computerized measurements in the superimposed global complex 
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was moderate. According to the principle of first wave onset and latest offset, intervals derived from the SGC 
will always be greater than in individual leads, explaining the higher prevalence of intraventricular conduction 
delay in our study.12 Consequently, redefinitions are required for SGC measurements.12 Still, computer derived 
pathological measurements should always be visually assessed to check for technical errors. Forth, choice of 
reference values: In lack of detailed descriptions and reference values in the ESC recommendations,16 we 
chose to add the specifications from Uberoi et al., while Brosnan et al. chose other reference values. These 
differences had special impact on the prevalence of long and short QT interval, 0.5% versus 2.3% and 0.7% 
versus 4.3%, respectively, and on the prevalence of common and training-related ECG findings as first-degree 
AV block (see online-only Data Supplement). Moreover, the huge difference in prevalence of early 
repolarization might be explained by the confusing definition of J point (see online-only Data Supplement) in 
addition to different reference values.17 Earlier participation in screening will also influence the results: the 
prevalence of abnormal findings will be lower in Italy where many athletes already are excluded owing to 
mandatory cardiac screening since 1982, and higher in Norway after the very first cardiac screening.  
   The prevalence of abnormal ECGs in other studies varies from 1.8% to 35%.3;4;6-10;15;18 Pathologic T-wave 
inversions and Q waves, which account for the majority of abnormal ECG findings in our study, vary from 0% to 
22.8% and 0% to 3.0%, respectively due to different reference values in other studies.3;4;6-10;15;18 Different 
reference values in our study could have reduced the prevalence of pathologic T-wave inversions to 0.9% and 
Q waves to 0% (see online-only Data Supplement).  
 
Recommended follow-up 
Mandatory echocardiography revealed one player with concentric hypertrophy and a normal ECG. If the lower 
limit for heart rate had been increased from 30 to 35 bpm, he would have been referred to follow up. The 
other two players with heart rate <35 bpm had type II second degree AV block. Riding et al found no athletes 
with hypertrophic cardiomyopathy by echocardiography alone .19 The two players with left ventricle 
hypertrophy due to hypertension would have been detected if players with repeated BP ≥160/100 mm Hg 
were referred for follow-up. Hypertension as the only manifested reason for restricted activity and treatment 
after screening, underscores the need for proper follow-up of young athletes with high BP.20 This increased the 
need for follow up with 22 players compared to the initial assessments (figure 3). Since all players underwent 
11 
 
echocardiography, auscultation was not performed. It might, however, have detected some among the nine 
players with grade I-II valve insufficiencies. No abnormal echocardiograms in any of the 106 players with 
abnormal ECGs according to the ESC’s recommendations only, indicate that the Seattle criteria increase the 
specificity without increasing the number of false negative findings. 
 
Differences related to ethnicity and sporting discipline 
We have presented all abnormal ECG findings related to ethnicity, but because of a small number of black 
players, we do not want to draw any conclusions. Anyway, the results are difficult to compare with other 
investigations, because some studies lack definition of ethnicity,3;4 while other studies use self-definition 
through questionnaires.6;21;22 Interestingly, none of these studies describe how they define athletes 
descending from parents with different ethnicity. Bhopal recommended that researchers should explain their 
understanding of the concepts of race or ethnicity and the classification they use.23 The prevalence of LVH in 
black athletes is usually reported to be high.7;18 Variations in cardiovascular diseases between African-born and 
Caribbean-born black people in New York exceed those between black and white people.24 Hence, 
environmental factors as birthplace and migration might also influence development of LVH. 
   Professional American football players who play at positions that require sprinting and similar bursts of 
physical activity associated with abrupt elevations in heart rate, like our outfield players, showed more 
abnormal ECGs than players at positions with lower levels of activity.3 This might contribute to higher 
prevalence of abnormal ECG findings in our athletes, compared to studies of athletes from other sporting 
disciplines (see online-only Data Supplement).  
 
Family history, symptoms and ECG findings   
There were no significant differences in family history of cardiovascular disease or symptoms during sports 
activity between players with abnormal versus normal ECGs. To assess retrospectively if the players “yes” or 
“no” should have warranted further follow up was not possible. It has previously been reported that 13.0% of 
the anonymous responders had been afraid of losing their license to play soccer.25 This might have led to 
underreporting in the present as well as other studies.7;22 Papadakis et al. describe no serious cardiac 
symptoms among 904 black athletes.6 On the other side, Wilson et al refer the highest prevalence of positive 
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family history of heart disease in 29.9% of junior athletes, even though cut-off for young age in family 
members was <35 years, in contrast to usually 50-55 years.26 This high score is probably owing to that 
participants were encouraged to ask their first and second degree relatives if the family cardiac disease history 
was unknown to them initially.  
 
Limitations 
Our results are representative for professional male soccer players in Norway, but not necessarily for athletes 
in other sporting disciplines and with different age and sex. Our application of on-screen measurements of 
superimposed global complex and averaged PQRST complexes cannot be compared with results from 
traditional measurements on paper; however, the method used in the present study gives significantly less 
variability.12 
   In ClickECG first wave onset and latest offset of the SGC were indicated in all averaged PQRST complexes, but 
only one averaged lead was visible each time. Accuracy of interval measurements would have increased 
further with newer software, which permits manual adjustment of the demarcation lines in the SGC in all leads 
synchronously.  
   The Regional Ethical Committee did not permit results of recommended follow-up examinations to be part of 
the study, consequently leaving the exact number of players with false positive or negative ECGs unknown. 
Lack of long-term follow-up data make it difficult to say whether or not the players who had abnormal ECG 
according to the ESC-based screening, but passed the ECG-test based on the Seattle criteria, safely could 
continue athletic activity, or belong to a group at higher than normal cardiovascular risk. 
  
Clinical impact and conclusions 
We have shown a marked reduction in ECG findings classified as abnormal when applying the Seattle criteria 
instead of the specified ESC recommendations in professional male soccer players. Echocardiographic 
screening alone only revealed one additional player with concentric hypertrophy, but he might have been 
detected anyway because of borderline bradycardia. None of the players with abnormal ECGs only according 
to the ESC’s recommendations had abnormal echocardiograms. We therefore consider the new Seattle criteria 
as an important step to reduce the burdens and costs of the follow-up that is required in athletes’ screening 
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programs.4;5;27 However, to make comparisons between studies meaningful, factors related to participants, the 
ECG recordings and technical specifications have to be thoroughly described.  
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Table 1.  Symptoms related to exercise and family history of cardiovascular disease reported by 587 
professional male soccer players in Norway 
Symptoms related to exercise  
 Chest pain 22 (3.7) 
Palpitations 25 (4.3) 
Syncope/ near syncope 17 (2.9) 
Breathlessness  35 (6.0) 
Family history in relatives <55 years  
 Sudden cardiac death 24 (4.1) 
 Cardiovascular disease 45 (7.7) 
 Hypertension 83 (14.1) 
 Diabetes 50 (8.5) 
Values are presented as n (%).  
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Figure legend 
Figure 1. 
Superimposed global PQRST-complex (SGC) computed from eight leads’ raw data in ECG recording of a 20 
years old professional white male Norwegian soccer player. The player had first-degree atrioventricular block 
with PR interval duration=230 ms, rSR’ pattern in V1 with QRS interval duration=120 ms and maximum P wave 
amplitude=0.252 mV in lead II.  
 
Figure 2. 
Flow-chart showing abnormal ECG findings according to the specified ESC recommendations and Seattle 
criteria. 
 
Figure 3. 
Flow chart showing the estimated need for follow up after BP recordings and abnormal ECG findings according 
to the ESC versus Seattle criteria. Abnormal echocardiographic results are displayed. 
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Table 8.  Other ECG findings in 587 male professional male football players in Norway and showing how 
slightly different reference values would have altered the number of normal and abnormal ECG findings  
 
Total 
n=587 (%) 
White 
n=497 (%) 
Black 
n=48 (%) 
Other 
n=42 (%) 
Epsilon waves      0 0 0 0 
Long PR interval >300 ms  0 0 0 0 
Nonvoltage criteria for LVH* according to 
 ESC with specifications 31 (5.3) 26 (5.2) 4 (8.3) 1 (2.4) 
Seattle 18 (3.1) 16 (3.2) 2 (4.2) 0 
Q waves 25% of the ensuing R wave 0 0 0 0 
Q waves ≥4 mm in ≥2 leads 2 2 0 0 
TWI ≥1 mm in groups in leads† 28 (4.8) 24 (4.8) 3 (6.3) 1 (2.4) 
 II-aVF 6 (1.0) 3 (0.6) 2 (4.2) 1 (2.4) 
I-aVL 0 0 0 0 
V2-V6 26 (4.4) 23 (4.6) 2 (4.2) 1 (2.4) 
Deep TWI-wave inversions‡ 5 (0.9) 3 (0.6) 1 (2.1) 1 (2.4) 
ST elevations ≥1 mm in groups in leads 402 (68.5) 330 (66.4) 36 (75.0) 36 (85.7) 
 
 
II-III-aVF 25 (4.3) 20 (4.0) 3 (6.3) 2 (4.8) 
V5-V6-I-aVL 16 (2.7) 14 (2.8) 1 (2.1) 1 (2.4) 
V2-V3 386 (65.8) 316 (63.6) 35 (72.9) 35 (83.3) 
V3-V4 115 (19.6) 94 (18.9) 12 (25.0) 9 (21.4) 
V2-V3-V4 397 (67.6) 327 (65.8) 35 (72.9) 35 (83.3) 
ST elevation ≥2 mm in lead§ 176 (30.0) 156 (31.4) 10 (20.8) 10 (23.8) 
 V1 3 (0.5) 2 (0.4) 0 1 (2.4) 
V2 143 (24.4) 115 (81.5) 17 (35.4) 11 (26.2) 
V3 96 (16.4) 85 (17.1) 8 (16.7) 3 (7.1) 
V4 10 (1.7) 9 (1.8) 1 (2.1) 0 
ST-T changes in leads V1-V4 in 
black/Africansǁ 
 15 (31.3) 7 (16.7) 
 V1 3 (6.3) 2 (4.8) 
V2 11 (22.9) 6 (14.3) 
V3 9 (18.8) 4 (9.5) 
V4 2 (4.2) 0 
Values are presented as n (%). *LVH (left ventricle hypertrophy) with associated left atrial enlargement, left-
axis deviation, ST segment depression, T wave inversion or pathological Q waves. †≥1 mm in depth in two or 
more leads V2-V6, II and aVF or I and aVL (excludes III, aVR and V1, and common ST-T changes in leads V1-V4 in 
black/Africans). ‡≥2 mm in ≥2 adjacent leads, except common ST-T changes in leads V1-V4 in black/Africans. 
§ST elevations >=2 mm in either V1, V2, V3 or V4, except when common ST- T changes in black/Africans. ǁST-T 
changes in either V1, V2, V3 or V4 in black/Africans, or others (two from Northern Africa, two from Asia, two 
with mixed ethnicity and one from South/Middle America; all with dark skin color). 
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